<SEC-DOCUMENT>0000902664-23-002777.txt : 20230503
<SEC-HEADER>0000902664-23-002777.hdr.sgml : 20230503
<ACCEPTANCE-DATETIME>20230503141848
ACCESSION NUMBER:		0000902664-23-002777
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230503
DATE AS OF CHANGE:		20230503

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		23883091

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Farallon Capital Partners, L.P.
		CENTRAL INDEX KEY:			0001175707
		IRS NUMBER:				943106322
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		C/O FARALLON PARTNERS, L.L.C.
		STREET 2:		ONE MARITIME PLAZA, SUITE 2100
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		(415) 421-2132

	MAIL ADDRESS:	
		STREET 1:		C/O FARALLON PARTNERS, L.L.C.
		STREET 2:		ONE MARITIME PLAZA, SUITE 2100
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FARALLON CAPITAL PARTNERS LP
		DATE OF NAME CHANGE:	20020617
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>p23-1397dfan14a.htm
<DESCRIPTION>EXELIXIS, INC.
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">SCHEDULE 14A</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">Proxy Statement Pursuant to Section 14(a)</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">of the Securities Exchange Act of 1934</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by the Registrant </FONT> <FONT STYLE="font-family: Wingdings">&#168; </FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by a Party other than the Registrant </FONT> <FONT STYLE="font-family: Wingdings">&#254; </FONT></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box:</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#168;</FONT></TD>
    <TD STYLE="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Preliminary Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#168;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#168;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Definitive Proxy Statement</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#254;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Definitive Additional Materials</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Wingdings; font-size: 12pt; line-height: 107%">&#168;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Soliciting Material Under Rule 14a-12</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 22pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Exelixis, Inc.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Registrant as Specified in Its Charter)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Partners, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Institutional
Partners, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Institutional
Partners II, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Institutional
Partners III, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Four Crossings Institutional
Partners V, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Offshore Investors
II, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital (AM) Investors,
L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital F5 Master I,
L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Healthcare Partners
Master, L.P.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Capital Management,
L.L.C.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Partners, L.L.C.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Institutional (GP)
V, L.L.C.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon F5 (GP), L.L.C.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Farallon Healthcare Partners
(GP), L.L.C.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Joshua J. Dapice</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Philip D. Dreyfuss </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Hannah E. Dunn</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Michael B. Fisch</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Richard B. Fried</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Varun N. Gehani</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Nicolas Giauque</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>David T. Kim</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Michael G. Linn</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Rajiv A. Patel</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Thomas G. Roberts, Jr.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Edric C. Saito</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>William Seybold</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Daniel S. Short </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Andrew J. M. Spokes </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>John R. Warren</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Mark C. Wehrly</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Richard Bollini</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Colby Clark</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Cameron Hillyer</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>David A. Posner</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Matthew Trentini</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Tomas J. Heyman</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>David E. Johnson</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Robert &ldquo;Bob&rdquo; Oliver,
Jr.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Caligan Partners LP</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>Caligan Partners Master Fund
LP</B></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Person(s) Filing Proxy Statement, if
other than the Registrant)<BR STYLE="clear: both">
</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt/85% Times New Roman, Times, Serif; margin: 0; text-align: justify">Payment of Filing Fee (check the appropriate box):</P>

<P STYLE="font: 12pt/85% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 85%">&nbsp;&#9745;</TD>
    <TD STYLE="vertical-align: bottom; width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">No fee required.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 85%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 85%">&nbsp;&#9744;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Fee computed on table below per Exchange Act Rule 14a-6(i)(4) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/85% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">1)</FONT></TD>
    <TD STYLE="width: 84%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Title of each class of securities to which transaction applies:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">2)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Aggregate number of securities to which transaction applies:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">3)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">4)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Proposed maximum aggregate value of transaction:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">5)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Total fee paid:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 85%">&#9744;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Fee paid previously with preliminary materials.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 107%">&#9744;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 93%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 107%">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">1)</FONT></TD>
    <TD STYLE="width: 84%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Amount Previously Paid:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">2)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Form, Schedule or Registration Statement No.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">3)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Filing Party:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">4)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt; line-height: 85%">Date Filed:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">On May 3, 2023, Farallon Capital Management,
L.L.C. and certain of its affiliates (&ldquo;Farallon&rdquo;) issued a press release (the &ldquo;Press Release&rdquo;) and a letter to
shareholders (together with the Press Release, the &ldquo;Materials&rdquo;) related to Exelixis, Inc., which Farallon also simultaneously
published to its website, located at www.FocusEXEL.com (the &ldquo;Website&rdquo;). A copy of the Materials is filed herewith as <U>Exhibit
1</U>.</P>

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Also on May 3, 2023, the website page
(the &ldquo;Website Page&rdquo;) filed herewith as <U>Exhibit 2</U> was published on the Website.&nbsp; From time to time, Farallon
or its fellow participants in the proxy solicitation may disseminate the Website Page and the Materials or portions thereof.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: right; font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B><U>Exhibit
1</U></B></FONT></P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>


<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: left"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>Farallon Capital Urges Exelixis Shareholders to Support
Change by Electing Its Three Highly Qualified Director Candidates</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>Files Definitive Proxy Materials and Sends Letter
to Exelixis Shareholders<BR>
<BR>
</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>Encourages Shareholders to Show that the Status Quo
Cannot Continue by Voting to Elect <U>All Three</U> of Farallon&rsquo;s Independent Nominees on the <U>WHITE</U> Proxy Card</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>Visit www.FocusEXEL.com to Obtain Important Information
and Sign Up for Updates </I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">SAN FRANCISCO May 3, 2023 &ndash; Funds managed by
Farallon Capital Management, L.L.C. (&ldquo;Farallon&rdquo;) own approximately 7.2% of the outstanding shares of Exelixis, Inc. (NASDAQ:
EXEL) (&ldquo;Exelixis&rdquo; or the &ldquo;Company&rdquo;), making it the Company&rsquo;s largest active shareholder. Today, Farallon
filed definitive proxy materials in connection with Exelixis&rsquo; 2023 Annual Meeting of Shareholders (the &ldquo;Annual Meeting&rdquo;),
which has been scheduled for May 31, 2023. Farallon also sent a letter today to the Company&rsquo;s shareholders outlining why change
is urgently needed in Exelixis&rsquo; boardroom and why shareholders should support Farallon&rsquo;s three independent director nominees
for election to the Board of Directors (the &ldquo;Board&rdquo;) at the upcoming Annual Meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For more information, shareholders can visit: www.FocusExel.com.
The full text of the letter is below:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">***</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dear Fellow Exelixis Shareholders:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Farallon Capital Partners, L.P. (together with certain
of its affiliates, &ldquo;Farallon,&rdquo; &ldquo;we&rdquo; or &ldquo;us&rdquo;) has owned Exelixis stock continuously since 2018. We
currently own approximately 7.2% of the outstanding shares of Exelixis, Inc. (&ldquo;Exelixis&rdquo; or the &ldquo;Company&rdquo;), making
us the Company&rsquo;s largest active shareholder.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Farallon is a fundamental value investor that takes
great pride in building strong, lasting relationships with boards and management teams. Our preference is to work constructively with
our portfolio companies to help drive sustainable value and growth. Only in situations where it is absolutely necessary do we publicly
criticize or challenge a Board&rsquo;s stewardship. This is one of those situations. As a result, we have nominated three candidates to
the Board of Directors at this year&rsquo;s May 31, 2023 Annual Meeting of Shareholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We are enthusiastic owners of Exelixis. In our view,
the cabozantinib franchise and related intellectual property are durable assets that are expected to generate more than $2 billion in
sales this year, and more next year. But despite this commercial success, Exelixis has not performed for shareholders. Since its IPO approximately
23 years ago, Exelixis has delivered a total return of just 35% for shareholders. By comparison, over that same period, the Nasdaq Biotech
Index has achieved a 287% return.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">With a commercialized drug and strong revenue growth,
this performance is unacceptable. And in our opinion, its cause is undeniable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exelixis insists on conducting a sprawling, unfocused
and massive R&amp;D effort without justification. The Company is planning to spend more than $1 billion on R&amp;D this year across almost
80 trials, in a multitude of indications and with a variety of modalities. Investors are not expecting much from all this spend, we believe,
as best evidenced by the muted reaction to a recent late-stage trial failure. By our math, Exelixis is valued significantly lower today
than the present value of the expected cash flow from cabozantinib. That is, investors believe there will be a negative return from all
the R&amp;D spend.</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We have tried to explain to Exelixis that unfocused
spending on R&amp;D is no longer acceptable. Recent history proves it is neither effective nor efficient, and not good for patients or
shareholders. But perhaps because the Exelixis Board has so few new members, with seven directors with more than 15 years of tenure and
three directors with more than 20 years of tenure, the Board is unwilling or unable to hew to the present imperative of R&amp;D specialization
and spending discipline.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company does, perhaps, recognize that its failure
to generate returns for shareholders makes it vulnerable to criticism. But even if the Company knows it may need to change, it is apparently
reluctant to do so, and seemingly only intends to change minimally &ndash; just enough to appear proactive and stave off a shareholder
referendum that risks even more change.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">But more change is precisely what is needed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">At this year&rsquo;s Annual Meeting, it is critical
that shareholders send Exelixis a clear message: Focus your R&amp;D on your best clinical prospects and in areas where you have identifiable
research advantages. This is not a message Exelixis wants to hear. And so, we need to be united and unequivocal. As a fellow shareholder,
we encourage you to elect our three Board candidates, all of whom are independent of Farallon. That will be the only way this Board will
hear shareholders&rsquo; resounding call for change. This contest is about spurring positive change at a company that has historically
been resistant to change.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Please vote for Tomas Heyman, David Johnson and Robert
Oliver &ndash; and reject the Company&rsquo;s nominee, Lance Willsey &ndash; by voting on the <U>WHITE</U> proxy card.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Exelixis Has Failed to Deliver Shareholder Value</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Even with a commercialized product delivering strong
and growing revenue, shareholders are worse off than they were five years ago. And over almost every other time period:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Exelixis Relative TSR</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>1-Year</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>3-Year</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>5-Year</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>15-Year</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>20-Year</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Since IPO</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>vs. Proxy Peers</I></FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(17%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(9%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(36%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(371%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(820%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(134%)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>vs. Close Peers</I></FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(23%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0%</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(37%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(517%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(962%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(191%)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>vs. Nasdaq Composite</I></FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(2%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(44%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(92%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(314%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(755%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(224%)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>vs. S&amp;P 400</I></FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(5%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(58%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(61%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(84%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(494%)</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(555%)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>vs. Nasdaq Biotech Index</I></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(12%)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(7%)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(41%)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(235%)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(504%)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #C00000">(252%)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Poor Decisions by the Board and Management Team
Have Led to This Underperformance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In our view, Exelixis&rsquo; long-term underperformance
is the result of the Board&rsquo;s failures and errors in judgment:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Inefficient and Unfocused
R&amp;D:</B> At a time when the cost of capital is increasing and biotech companies of all sizes are prioritizing spending control and
making hard choices, Exelixis is trending in the opposite direction. In 2023, the Company plans to spend more money than ever on R&amp;D,
with much of it going to discovery and pre-clinical projects in scientific and clinical areas where we believe the Company lacks differentiation
and a competitive advantage. </FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0"><SUP>1</SUP> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; line-height: 107%">Source:
FactSet and Bloomberg. Data as of March 17, 2023. &ldquo;Proxy Peers&rdquo; include ACADIA Pharmaceuticals, Alkermes, Alnylam Pharmaceuticals,
BeiGene, BioMarin Pharmaceutical, Blueprint Medicines, Emergent BioSolutions, Horizon Therapeutics, Incyte, Ionis Pharmaceuticals, Jazz
Pharmaceuticals, Natera, Neurocrine Biosciences, NovoCure, Sarepta Therapeutics, SAGE Therapeutics, Seagen, Ultragenyx and United Therapeutics.
&ldquo;Close Peers&rdquo; include Alnylam Pharmaceuticals, BioMarin Pharmaceutical, Incyte, Ionis Pharmaceuticals, Neurocrine Biosciences
and Seagen. Peer data refers to median.</FONT></P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Lack of a Clearly Articulated
R&amp;D and Capital Allocation Strategy:</B> Exelixis has failed to communicate a coherent R&amp;D strategy to the investment community.
This type of large, unfocused R&amp;D program without an organizing principle or strategy creates the perception of complexity and a lack
of productivity, making it difficult to attract interest from investors. Given the lack of an R&amp;D thesis, it is not surprising that
over the last five years many of the active money managers that owned Exelixis stock have sold down or exited their positions completely.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Suboptimal Capital Allocation
and an Inefficient Balance Sheet:</B> At the end of 2022, Exelixis had more than $2 billion of cash and marketable securities on its balance
sheet. With a cash hoard so large, Exelixis has not had to be disciplined with its spending. We appreciate that Exelixis responded to
our call to return capital (even if belatedly), but it should distribute even more to ensure more focus. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Inability to Achieve Stated
Targets:</B> At the 2020 JP Morgan Conference, Exelixis laid out a path to reaching $4 billion in net revenue from cabozantinib by 2025.
The market reacted positively. However, management has failed to execute on this vision and analysts are now expecting just $2.3 billion
in revenue in FY 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Insufficient Board Refreshment:</B>
The average tenure of the directors currently on the Board is <I>16 years</I>, which is among the highest in the entire Nasdaq Biotech
Index. Seven of the eleven current directors have served on the Board for more than 15 years, and three have served for more than 20 years.
</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Lack of Board Alignment with
Shareholders:</B> While Exelixis&rsquo; management promotes the success of cabozantinib and the promising pipeline of new drugs, the Board
and CEO have been aggressively selling stock, realizing over $110 million from sales of Exelixis shares over the past ten years. As a
result, most of the directors no longer have a substantial financial investment in the Company.<SUP>2</SUP></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Ineffective Compensation Program:</B>
Despite the Company&rsquo;s long-term underperformance, the CEO&rsquo;s compensation has increased dramatically over the last five years.
In 2022, with the stock down more than 12% on the year, President and Chief Executive Officer Michael Morrissey was paid $16.8 million.
That was twice what he made in 2021, when the stock also fell, and seven times what he made in 2020. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Our Engagement with Exelixis Has Been Disappointing</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Given these many issues &ndash; and our large investment
&ndash; we have sought to engage with Exelixis to find a path forward that would benefit shareholders and patients. At every turn, Exelixis
has sought to minimize change and preserve its discretion to resist outside influence.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Initially, Exelixis offered to provide us with data
that supposedly supported the need for the Company&rsquo;s bloated R&amp;D program. We suspect they did not think we would agree to their
offer. And so, when we agreed to sign a standard confidentiality agreement and restrict our ability to buy and sell Exelixis securities
for nine months, the Company quickly did a <I>volte face</I>. Suddenly, the Company claimed, Farallon was the one seeking too much data
and access when, in fact, it had been the Company&rsquo;s Chairman who offered to justify Exelixis&rsquo; spending with private data and
the Company that required that Farallon interact with Exelixis&rsquo; CEO regarding the information. We have come to doubt that the Company&rsquo;s
offer to show us the justification for the $1 billion in spending was ever genuine.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0"><SUP>2 </SUP><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; line-height: 107%">Source:
FactSet.</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">What we have learned from the Company&rsquo;s refusal
to sign the very confidentiality agreement <I>it</I> drafted was that the Board did not actually want to convince us of anything. It wanted
instead to shroud its decision-making behind a curtain, claiming it had data without having to reveal it.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Faced with mounting evidence of a board stubbornly
averse to change and resistant to outside input, we decided to take our case directly to shareholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>We Believe Change Is Warranted</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our Board candidates are leading executives, directors
and investors. If elected, they will bring much-needed fresh perspectives, independence and a sense of urgency to the Exelixis Board.
Together, they are committed to working constructively on behalf of all shareholders to drive change.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Tom Heyman</B>&nbsp;led Johnson
&amp; Johnson&rsquo;s venture capital group, which managed approximately $1.5 billion in capital and oversaw investments in over 100 companies
and assets. He is also the former Global Head of Business Development for Janssen Pharmaceuticals, where he was responsible for sourcing
and executing hundreds of M&amp;A and licensing transactions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Dave Johnson</B>&nbsp;has
spent over a decade investing in and serving on the boards of small- and mid-cap life sciences companies and has strong expertise in biotech
capital allocation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Bob Oliver</B>&nbsp;is the
former CEO of Otsuka America Pharmaceutical (&ldquo;Otsuka&rdquo;). He has a track record of building strong portfolios and commercializing
assets across different markets. While at Otsuka, he built the company&rsquo;s commercial capabilities and developed ABILIFY into the
number-one selling pharmaceutical in the U.S.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Realizing the strength of our candidates, the Company
has indicated that it will support two of our nominees, Tom Heyman and Bob Oliver. However, we do not believe this is sufficient. And
we believe the Board knows this too. As such, we believe shareholders should see this ploy for what it is: a tactical gambit to avoid
meaningful change, rather than self-realized refreshment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">To drive real change, we believe that it is essential
that all three of Farallon&rsquo;s candidates are elected. Shareholders must send an unequivocal message that the status quo is not a
viable path forward.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">To do so, you must withhold from at least one of the
Board&rsquo;s incumbent directors. We are strongly recommending shareholders reject incumbent director Lance Willsey. The Board claims
that Dr. Willsey should serve on this Board for his 27<SUP>th</SUP> consecutive year because of his &ldquo;skill as a physician.&rdquo;
But, as far as we can tell, Dr. Willsey has not had an active medical license since the 1990s. Today, he is a professional race car driver,
not an oncologist. He does not serve on any other public company boards; he does not practice medicine; he is not a member of American
Society of Clinical Oncology (ASCO), the professional society of oncologists; he left his investment fund more than 20 years ago, and
he does not appear to have had full-time employment in the medical, financial or any other field since. Additionally, Dr. Willsey has
sold $10 million worth of stock in recent years, which reflects, in our view, a lack of optimism and complete lack of alignment with shareholders.
Despite these facts, the Board is seemingly content to have him remain on the Board indefinitely, rather than replace him with Dave Johnson,
who would bring current biotechnology expertise, a shareholder perspective and much-needed independence and objectivity to the Board&rsquo;s
deliberations.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Frankly, we do not blame Dr. Willsey for wanting to
remain on this Board. We believe that Dr. Willsey has not seen a patient in 25 years and has not invested professionally in 20 years,
but he benefits handsomely from his association with Exelixis. He received more than $440,000 for attending Board meetings last year while
Exelixis appears to have been sponsoring his automotive racing team for no discernible reason. What is less clear is how Dr. Willsey helps
Exelixis shareholders.</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Willsey&rsquo;s continuing presence on this Board
is symptomatic of all that is wrong with Exelixis: He is proposed for yet another year of service because he has <I>always</I> been a
Board member. The Board seemingly believes next year should be just like last year. But last year, like almost every year, Exelixis underperformed
its potential and its peers. It is time to break the cycle.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Reelecting Dr. Willsey to this Board would send the
unmistakable message to the directors that they can continue to oversee the business in the same comfortable way to which they have become
accustomed without accountability to shareholders. We believe shareholders deserve better.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>The Path Forward</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We believe Exelixis' Board needs a jolt of fresh thinking.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In our view, the election of Dave Johnson &ndash; an
experienced life sciences investor and director &ndash; as a replacement for Dr. Willsey, a long-tenured, underqualified and underperforming
incumbent director, will dramatically enhance the quality, objectivity and urgency of the Board&rsquo;s deliberations. As importantly,
the election of our three candidates would, in our view, serve as a mandate for meaningful change.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We urge you to vote the <U>WHITE</U> proxy card today
FOR the election of our candidates, Tom Heyman, Dave Johnson and Bob Oliver, and to &ldquo;withhold&rdquo; on Lance Willsey.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Please
visit </FONT>www.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">FocusEXEL</FONT>.com <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">to
sign up for updates and learn how to vote on the <U>WHITE</U> proxy card to elect our full three-member slate. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Thank you for your support.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">***</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>VOTE THE <U>WHITE</U> PROXY CARD TO FOCUS EXEL AT
THIS YEAR&rsquo;S ANNUAL MEETING OF SHAREHOLDERS. VISIT WWW.FOCUSEXEL.COM TO SIGN UP FOR IMPORTANT UPDATES.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>We urge shareholders to vote &ldquo;FOR&rdquo; each
of the Farallon Nominees on the <U>WHITE</U> Proxy Card and to &ldquo;WITHHOLD&rdquo; on Lance Willsey.</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>If you have already voted using the Company&rsquo;s
proxy card, you have every right to change your vote by completing and mailing the enclosed <U>WHITE</U> Proxy Card in the pre-paid envelope
or by voting via Internet or by telephone by following the instructions on the <U>WHITE</U> Proxy Card.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">***</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>About Farallon</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Farallon Capital Management, L.L.C., is a global investment
firm founded in 1986 and registered as an investment advisor with the United States Securities and Exchange Commission since 1990. Farallon
seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing
capital preservation. More information on Farallon is available at www.faralloncapital.com.</P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Disclaimer</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">This press release does not constitute an offer to
sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. This press release does not
recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of
the Company will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release and the
discussions and opinions herein are for general information only, and are not intended to provide investment advice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">This press release contains forward-looking statements.
Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying
assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations,
services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified
by the words &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;believes&rdquo;, &ldquo;intends&rdquo;, &ldquo;estimates&rdquo;,
&ldquo;plans&rdquo;, &ldquo;will be&rdquo; and similar expressions. Although Farallon (as defined below) believes that the expectations
reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are
subject to various risks and uncertainties&mdash;many of which are difficult to predict and are generally beyond the control of Farallon
or the Company&mdash;that could cause actual results and developments to differ materially from those expressed in, or implied or projected
by, the forward-looking information and statements. These risks and uncertainties are enumerated in the Company&rsquo;s public filings.
In addition, the foregoing considerations and any other publicly stated risks and uncertainties should be read in conjunction with the
risks and cautionary statements discussed or identified in the Company&rsquo;s public filings with the United States Securities and Exchange
Commission (the &ldquo;SEC&rdquo;), including those listed under &ldquo;Risk Factors&rdquo; in the Company&rsquo;s annual reports on Form
10-K and quarterly reports on Form 10-Q. The forward-looking statements speak only as of the date hereof and, other than as required by
applicable law, Farallon does not undertake any obligation to update or revise any forward-looking information or statements. Certain
information included in this material is based on data obtained from sources considered to be reliable. Any analyses provided to assist
the recipient of this material in evaluating the matters described herein may be based on subjective assessments and assumptions and may
use one among alternative methodologies that produce different results. Accordingly, any analyses should also not be viewed as factual
and also should not be relied upon as an accurate prediction of future results. All figures are unaudited estimates and, unless required
by law, are subject to revision without notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Funds managed by Farallon Capital Management, L.L.C.
(&ldquo;Farallon Capital Management&rdquo;) currently beneficially own shares of the Company. These funds are in the business of trading
(i.e., buying and selling) securities and may continue trading in the securities of the Company, subject to applicable law. You should
assume such funds will from time to time sell all or a portion of their holdings of the Company in open market transactions or otherwise,
buy additional shares (in open market or privately negotiated transactions or otherwise), or trade in options, puts, calls, swaps or other
derivative instruments relating to such shares, subject to applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Consequently, Farallon Capital Management&rsquo;s beneficial
ownership of shares of, and/or economic interest in, the Company may vary over time depending on various factors, with or without regard
to Farallon Capital Management&rsquo;s views of the Company&rsquo;s business, prospects, or valuation (including the market price of the
Company&rsquo;s shares), including, without limitation, other investment opportunities available to Farallon Capital Management, concentration
of positions in the portfolios managed by Farallon Capital Management, conditions in the securities markets and general economic and industry
conditions. Farallon Capital Management also reserves the right to change the opinions expressed herein and its intentions with respect
to its investment in the Company, and to take any actions with respect to its investment in the Company as it may deem appropriate, and
disclaims any obligation to notify the market or any other party of any such changes or actions, except as required by law.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>Important Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Farallon Capital Partners, L.P. (together with its
affiliates, &ldquo;Farallon&rdquo;), together with certain other persons acting as participants in the solicitation of shareholders of
the Company by Farallon in connection with the Company&rsquo;s 2023 annual meeting of shareholders (the &ldquo;2023 Annual Meeting&rdquo;),
have filed a definitive proxy statement and accompanying white proxy card with the SEC on May 3, 2023. Shareholders are advised to read
the definitive proxy statement and any other documents related to the 2023 Annual Meeting as they contain important information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The definitive proxy statement and other relevant documents
are available free of charge on the SEC&rsquo;s website at https://www.sec.gov, as well as on Farallon&rsquo;s website in connection with
the 2023 Annual Meeting at https://www.FocusEXEL.com. Shareholders may also direct a request to Farallon&rsquo;s proxy solicitor, MacKenzie
Partners, Inc., 1407 Broadway, 27th Floor, New York, New York 10018 (shareholders can call toll-free at 1-800-322-2885).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>Contacts</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For Investors:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">MacKenzie Partners, Inc.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Bob Marese, 1-800-322-2885</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">proxy@mackenziepartners.com</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For Media:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Longacre Square Partners</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Dan Zacchei / Charlotte Kiaie, 646-386-0091</P>

<P STYLE="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">Farallon@longacresquare.com</P>



<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>


<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="text-align: right; font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt"><B><U>Exhibit
2</U></B></FONT></P>

<P STYLE="text-align: center; font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 8pt">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="height: 357pt; width: 468.75pt"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1N!<\# 2(  A$! Q$!_\0
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MDHHH **** "BBB@ I*** "BBB@0444E !1110 E%%%, HHHH *2BB@04444
M%%%% !2444 %%%% !1110(2BBB@ I*** "BBB@ I*** "BBBF(**** "DHHH
M **** "DHHH$%)2TE !1110 4444 %)110 4444Q!1110 4E%% !1110 4E+
M24 %%%)0(**** "BBB@ I*** "BBBF!U-%%)7*>F%%%% !1113$%)2TE !11
M10 4444 %)110(**** "BBDH **** "DHHIB"BBB@ I*** "BBB@ HHHH *2
MBB@0444E !1110 444E !1110(**** "DHHH **** "BBBF 4E%% @HHHH *
M2BB@ HHI* "BBB@ HHHH$%)110 4444 %%%%, I*** "BBB@0444E !1110
ME%%% !1110 4E%% @HHHI@%%%% !2444 %%%)0 4444""DHHH **** "BBB@
M I*** "BBB@04444 %)110 4444 %)113$%)2TE !1110 4444 %)110 444
M4""BBDH **** "DHHI@%%%% !2444""BBB@ HHHH *2BB@ HHHH ****!!24
M44 %%%)0 4444 %)110 4444""BBBF 4E%% !1110 4E%% !1124""BBB@ H
MHHH *2BB@ HHHIB"BBB@ I*** "BBB@ HHI* "BBB@0E%%% !1110 4E%% !
M1113 ****!'44445RGJ!1113$%%%)0 4444 %%%% !2444""BBB@ HHHH 2B
MBB@ I*** "BBBF(*2EI* "BBB@ HHHH *2EI*!!1110 4E%% !1110 E%%%
M!1110(*2EI* "BBB@ HHHI@%)2TE @HHHH *2EI* "BBDH **** "BBB@04E
M+24 %%%% !1113 *2EI* "BBB@0444E !1110 4E%% !1110 4E+24""BBB@
M HHHI@%)2TE !1124 %%%% @I*6DH **** "BBB@ I*6DH ****!!1110 4E
M+24 %%%% !2444P"BBDH$%%%% !1110 444E !1110(**** $HHHH *2BBF
M4444 %%%)0(**** "BBB@ HHI* "BBB@ HHHH$%)110 444E !1110 444E
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MD)O$-Q97.O7DNGPK%:%\1J@P"!QG'N>:RZ6DKI2LK&AZ!\*?^0M?_P#7 ?\
MH5=YXL_Y%/5/^O=OY5P?PI_Y"U__ -<!_P"A5WGBW_D4M4_Z]V_E7)4_B&4O
MB/ Z2BBNPU/I5?N#Z5X9XZ_Y'34O]]?_ $!:]S7[@^E>&>.O^1TU+_?7_P!
M6N.A\1E#<YVK>E:=+JVJ6UA#P\[A0<=!W/X#)JI77?#8Q#QA%YF-QAD$>?[V
M/\,UU2=DV:/8]6T70K'0;);>RA"\#?(1\TA]2:MR7MK"^R6YA1_[K2 &B\CF
MFL9XK>7RIGC98Y/[K$<&O"-6\,ZYID[F]LIVR23,H+JWON']>:XX1YWJS)*Y
M[ZK*ZAD8,IZ$'(KR[XHVVF6\MH8((TOY2SR,@QE?<>I/?V-<7I>N:GHLV^QN
MY(><LF<JWU7H:AU+4KO5[Z2\O93),_4]@.P ["MH4G&5[E*-F5****Z"PI**
M* "O5/A-_P @W4O^NR_RKRNO5/A-_P @W4O^NR_R-95O@)EL>B45R7Q(#'P?
M,$!)\V/I]:\8V3_W9/R-<\*7.KW(4;GTI7S7=E#>SF+_ %?F-MQZ9XII691E
MA(!ZG-1UTTZ?)U*2L%>I_#/Q-YT1T.[?YXP6MB>Z]U_#J/Q]*\LJ6UN9K.ZB
MN;=RDT3!T8=B*J<>96&U<^A]8TN#6=*N+"X'R2K@'NI[$?0U\^:C83Z9J$]E
M<KMFA<JP]?<>QKWKPWKL/B'1HKV/"R?=FC!^XXZC^HK(\4>"H=?UBPO053:X
M6Z]7C'(_'M]#[5RTI\C:D0G8I_#3P_\ V?I+:I.F+B\'R9'*Q]OSZ_E6QXR\
M1+X>T-Y$8?:YLQP+[]V_#_"MYFBMK<LQ6.*)<D] J@5X+XM\0/XBUR2Y!86T
M?R0(>R^OU/6B"=2=V"U9ALS.Y=B69CDD]S2445VEGKWPG_Y%V\_Z^S_Z M=[
M7!?"?_D7;S_K[/\ Z M3_%(.?"L.P,3]K3I_NO7#-<U2QF]SMJ0D $GI7S3L
MN/[LGY&D83*,L) /4YK3ZOYCY1LNWS7V_=W''TIE%%=99Z/\(_\ C_U/_KDG
M\S7;^-_^1,U3_KE_45Q'PC_X_P#4_P#KDG\S7;^-_P#D3-4_ZY?U%<53^+]Q
M#W/ :2BBNTH**** "BBB@ I*** "BBB@ HHHH$)1110 4E%% !1110 4E%%
M!1113$%%%% !2444 %%%% !2444""DHHH **** "BBB@ I*** "BBBF(****
M "DHHH **** "DI:2@ HHI*!!1110 4444 %)110 4444P"BBB@04E%% !24
MM)0 4444 =31117,>F%%%% !2444""BBB@ HHI* "BBB@ I***8@HHHH *2B
MB@ HHHH **** "DHHH$%%%)0 4444 %%%)0 4444""BBB@ I*** "BBB@ HH
MHI@%)110(**** "DHHH ***2@ HHHH ****!!2444 %%%% !1113 *2BB@ H
MHHH$%>B_"G_6ZK_NQ?\ LU>=5Z+\*?\ 6ZK_ +L7_LU9U?@9,_A/0M0T^WU2
MQELKM"\$N-RAB,X(/4>XK _X5[X;_P"?.3_O\_\ C6IXBU.71M!NM0A1'DA"
MD*^<'+ =OK7GO_"T]3_Y\+3_ ,>_QKFA&;7NF45)[&YX@\#:%9>'[ZZM;9TF
MAA+HQE8X(YZ$UY/78ZG\1=1U/3+BQ>TMHTG38S)NR!^)KCJZ::DE[QK%-;G/
M:^Q-W&O8)G\R?\*T-$B$>GA^\C$G^7]*H:^A%U$_8IC\C_\ 7J[H<PDL?+[Q
ML1^!YKKE_#1RP_CNYITE%%8'62QG*D&L?7H@;0/CYD?@^Q_R*V(AA2:Q=?G
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MPOL<I]UN,Y'I69\48D?PQ%(0-R7*[3]0<U-.4HRY6)-IV/'Z2BBNLT"BBB@
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M/4?^$-\._P#0(MO^^:\2U^VBL_$6HVT*A8HKF144=@&.!6Y_PLCQ+_S]1?\
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MM)0 4444""BBBF 4E+24 %%%% !2444 %%%)0(**** "BBB@ HHI* "BBB@
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M>QJX-*5V954W!J)RU;&CZ?O874J_*/N ]SZT^VT$B0-<2*5'\*]ZVE4*H50
M!P *VJ5%:R.>C1=[R%HHHKG.P***2@ HHHH *2BB@0444E !1110 4444 %%
M%)0 4444""BBB@ HHI* "BBB@ HHI*8!1110(2BBB@ HHHH ***2@ HHHH *
M***!!2444 %%%)0 4444P"BBDH ****!!1110 444E !1110 4444""BBDH
M**** "DHHH ***2@ HHHH$%%%%, HHI* "BBB@ HHI* "BBB@04E%% !1110
M 444E !1110 4444Q!1124 %%%% !1110 4E%% !1124""BBB@ HHHH 2BBB
M@ HHHI@%%%)0(**** "DHHH **** $HHHH ****!!1110!U-%%%<QZ8444E
M!1124 %%%%,04444 )1110 4444 %%%% A**** "BBDH **** "BBDH ****
M!!1110 E%%% !1110 4444P$HHHH$%%%% "4444 %)110 4444 %%%% A***
M* "BBBF 4444 )1110 4444""DHHH ***2@ HHHH **** $HHHH$%%%%, HH
MHH 2BBB@ I*6DH$%%%% !2444 %%%% !1110 4E%% @HHHH **** "DHHH *
M**2@ HHHIB"DHHH **** "BBB@ I*** "BBB@0444E !1124 %%%%, HHHH
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M2BH]]&^@"2DJ/>*-XH$245'Y@HWB@!]%1[Q1O%,"2BH]XHWB@"2BH]XI-XH
MDHJ/>*-XH$245'O%&\4 245%O%&\4 245'YE&^@"2BHM]&\4 244S>*<#0(6
MDHHI@%%(3BF[Q0 ^BH]XHWBD ^BH]XHWBF!)14>\4;Q0(DHJ/>*3>* )**CW
MBC>* 'T4S>*-XH ?14>\4;Q1<0^BF;Q1O%%P'T4S>/6DWCUHN!)14>\4;Q0
M^BH]XHWBF!)14>\4;_>@1)14>\4F\4 245'O%&\4 24E,WBC>* 'T5'O%&\4
M /HIF\4;Q0(?14>\4;Q0!)14>\4;Q0 ^BF;Z3>*+@245'OHWBF ^BF;Z-]*X
MA])3-PHWBG<!]%,WBC>* 'T5'O%&\4 /HIF\4;Q0 ^BF;Q1O% A]%,W"E!H
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M.(>UGW+_ /:;?\\__'O_ *U']IM_SS_\>_\ K50HH]G$/;3[E_\ M)O^>?\
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M\=3^%8EQ:P^(?BI;W.@7S6-U!;>=>2O9LC*Z\$^6X&2P9?\ /6_;>\U;17_
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M^IP*Q9[VSUWR3_85MIEE#*INKJSC=BBDXYR2*O&]O/%.OV>GZ &L--L/^/8
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M&IK?[QJ9[%P^(T$Z4ZF)TI]9(Z HHHI@%%%% !2444 %%%%, HHHH$)1110
M4E%% !1110 4E%% !1110(**** "DHHH **** "BBB@04E%% !1124P.JI**
M*YCTPHHHH **** "DHHH$%%%)0 4444 %%%)0 4444""BBB@ I*** "BBB@
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M.T'3;]=._L?4IYF$FG+<B50N#EAC@=%Z8'-3&HURKNE_7]7&U=R_KL8'P_\
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M7I2/TK$[#)O_ +R?C5.KE_\ >3\:IUO#X3BJ_&PHHHJS,Z>'_DFUU_V$$_\
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MIK?[QJ&IK?[QJ9[%P^(OITI],7I3ZS.@**** "DHHH ****8!1110(*2BB@
MHHI* "BBB@ I*** "BBB@04444 %)110 4444 %%%% @I*** "BBBF E%%%
M'4T445S'IA1110 4E%% @HHI* "BBB@ HHI* "BBB@04444 %)110 4444 %
M%%%, I***!!1110 4E%% !1124 %%%% !44G2I:BDZ4",+5OO1_C_2LZM'5O
MO1_C_2LZNBG\)YM;XV%20?\ 'Q'_ +X_G4= )!R#@UH9':^/-#U:Y\;:I-;Z
M7>RQ/(I5X[=V4_*O0@56TB7Q=HEL\%EHUR%9]^Y]/+,#@#@E<CI64/%?B,
M:_JH X %Y)_C2_\ "6>)/^A@U7_P-D_QK)1ER\KM^)5U>YH*?&:V]]#]CU7;
M?,&N";9\N?KBI9+OQS)I$.E&WU=;2%=JHMNX)'H3C)K*_P"$L\2?]#!JO_@;
M)_C1_P )9XD_Z&#5?_ V3_&CE?9!=$1\.ZZ3DZ-J.?\ KU?_  KH_"6D:E8C
M6I;O3[NWC_LR8;Y8609P.,D5@_\ "6>)/^A@U7_P-D_QJ.;Q+KUS"\,^MZE+
M$XVNDEW(RL/0@GFFU-JVGX@K(RZ***T)"BBB@ HHHH *56*L&4D$'(([4E%
M#I)))7+R.SN>K,<FFT44 %%%% "JQ5@RDA@<@@\BEDDDE<O([.YZLQR:;10
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MEAS]#7*44^5W3;%<****L04444 %%%% !3XYI823%(Z$C!*L1D4RB@ HHHH
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M* "BBB@ I*** "BBB@04E+24 %%%% !1113 *2EI*!!1110 4E+24 %%%)0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "IK?[QJ&K%LI))J9;%P^(NITIU-4<4ZLSH"BBBF 4444""BBDH ****
M$HHHH ***2@ HHHH$%%%% !1124 %%%% !1110 444E @HHHH *2BBF 444E
M !1110(ZJBBDKF/3"BBB@ I*** "BBB@ I*** "BBB@0444E !1110 4444P
M"BBDH ****!!1124 %%%% !2444 %%%% @HHI* "D(S2T4 5Y85D4JR@@]C5
M(Z9;Y_U?ZFM3%)MIW:V)<4]T97]F0?\ //\ 4T?V9!_SS_4UJ;11M%%WW%[.
M/8R_[,@_YY_J:/[,@_YY_J:U-M)M%%WW%[./8S/[,@_YY_J:3^S8?^>?ZFM3
M;1MHN^X>SCV,O^S8?[GZFC^S8/[GZFM3;2;:+ON'LX]C,_LV#^Y^IH_LV'^Y
M^IK3VT;:+ON'LX]C,_LV'^Y^II/[-A_N?J:U-M)MHN^XO9Q[&9_9L/\ <_4T
M?V;#_<_4UI[11M%.[[A[./8S/[-A_N?J:/[-A_N?J:T]HHVBB[[A[./8S/[-
MA_N?J:/[.A_N?J:TMHHVBB[[A[./8S?[.A_N?J:3^SH?[GZFM/:*-HHN^X>S
MCV,S^SH?[GZFC^SH?[GZFM/;2;11=]PY(]C-_LZ'^Y^IH_LZ'^Y^IK2VBC;1
M=]Q<D>QF?V=#_<_4T?V=#_<_4UI[12;11=]PY(]C-_L^'^Y^IH_L^'^Y^IK2
MVT;:+ON')'L9O]GP_P!S]31_9\7]S]36EMHVT7?<.2/8S/[/B_N?J:/[/B_N
M?J:TMM&T47?<.2/8S?[/B_N?J:/[/B_N?J:TMHHVT7?<.2/8S?[/B_N?J:/[
M/B_N?J:TMM)M%%WW%R1[&=]@B_N?J:/L$7]S]36CM%&T47?<.2/8S?L$7]S]
M31]@B_N?J:TMHI-M.[[AR1[&=]@B_N?J:/L$7]S]36CM%&VB[[AR1[&=]@B_
MN?J:/L$7]P_F:T=HI-HHN^X<D>QG_8(O[GZFD^P1?W/U-:.T4;11=]PY(]C.
M^P1?W/U-'V&+^Y^IK1VBC:*+ON+DCV,[[#%_=_4T?88O[OZFM':/2DVBB[[A
MR1[&?]AB_N_J:3[#'_=_4UH[11MHN^X<D>QG?88_[OZFC[#'_=_4UH[:3;1=
M]PY(]BBMC$#]S]35M$"@ # J3;1B@:26P"@BEI*!D,D0<$$ BJIL8O[GZFK^
M*3%&I+BGN9_V*/\ N_J:/L4?]W]36AMHVT7?<7)'L9_V*/\ N_J:/L4?]W]3
M6AMI-M.[[AR1[%#[%'_=_4TGV*/^[^IK0VT;:+ON'+'L9_V*/^[^IH^Q1_W?
MU-:&VDVT7?<.2/8H?8H_3]:/L4?]W]:O[:-M%WW%RQ[%#[''_=_6D^QQ_P!W
M]:T-M)MHN^X<L>Q0^QQ_W?UH^QI_=_6K^VC;1=]PY8]BA]C3^[^IH^QI_=_4
MU?VT;:+ON'+'L4/L:?W?UH^QI_=_6KVVC%%WW#E78H_8T_N_K2?8T_N_K5_;
M1MHN^XN5=BA]C3^[^M'V1/[OZU>VT;:+ON'+'L4?LB?W?UH^R)_=_6KVVC;1
MKW#E78H_9$_N_K2?9$]/UJ_MI-HHU[ARKL4?LB>GZT?9$]/UJ]MHVT]>X<J[
M%'[(GI^M'V1/3]:O;:3;1J'*NQ2^R)Z?K2?9$]/UJ]MHVT:BY5V*/V5?3]:/
MLJ^GZU>Q28HU[ARKL4OLJ^E'V5?3]:NXHVT:ARKL4OLJ^E'V5?2KNVC;1J'*
MNQ1^RKZ4?95]*N[:-M&H<J[%+[*OI1]F7TJ[MHVT:]PY5V*7V9?2C[,OI5W;
M2;:-0Y5V*?V9?2D^S+Z5=VT;:-1<J[%+[,OI1]F7TJ[MI-M&O<.5=BG]F7TH
M^S+Z5<VT;:-0Y5V*?V9?2C[,OI5S;28HU#E78J?9E]*/LR^E6\48IZARKL5!
M;+Z5.D848 J3%+B@$D@ HHHH&%%%%, HHI*!!1110 4E%% !1124 %%%% @H
MHHH ***2@ HHHH **** "BBDH$%%%% !1124P"BBDH ****!!1110!U-%%%<
MQZ84E+24 %%%% !24M)0 4444""BBDH **** "BBB@ HHI*8!1110(***2@
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M &*W_P">?_CQH^Q6_P#SS_\ 'C5BBCV<>P>UJ?S,K_8K?_GG_P"/&C[%;_\
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M*W]GVO\ SR_\>/\ C1_9]K_SR_\ 'C_C5FBCDCV#VL^[*W]GVO\ SR_\>/\
MC1_9]K_SR_\ 'C_C5FBCDCV#VL^[*W]GVO\ SR_\>/\ C1_9]K_SR_\ 'C_C
M5FBCDCV#VL^[*W]GVO\ SR_\>/\ C1_9]K_SR_\ 'C_C5FBCDCV#VL^[*W]G
MVO\ SR_\>/\ C2?V?:_\\O\ QX_XU:HHY(]@]K/NRK_9]K_SR_\ 'C_C1_9]
MK_SR_P#'C_C5JBCDCV#VL^[*O]GVO_/+_P >/^-']GVO_/+_ ,>/^-6J*.2/
M8/:S[LJ_V=:_\\O_ !X_XT?V=:_\\O\ QX_XU:HHY(]@]K/NRK_9UK_SR_\
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MV#VD^[*G]F6?_/'_ ,>/^-']F6?_ #Q_\>/^-6Z*.2/8/:3[LJ?V99_\\?\
MQX_XT?V99_\ /'_QX_XU;HHY(]@]I/NRH--LP?\ 4_\ CS?XU0U"U2UD1HS\
MDF<*3DJ1_3D5M5DZR?FM_P#@7]*RJPBHW2-Z%23FDV4U-.IB=*?7,>@%)113
M ***2@ HHHH *2BB@ HHHH$%%%% !2444 %%%% !1110(*2BB@ HHHI@)111
M0 4E%% @HHHH **** "DHHH ZFBBBN8],***2@ HHHH$%%%% !2444 %%%%
M!1113 *2BB@04444 %)110 444E !1110 4444""DHHH **** "BBBF E1R=
M*DJ.3I2 2S^]+^']:MU4LOO2_A_6K=>A0_AH\'%?QF%%%%;',%%%% !1110
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M%BOXS"BBBMCF"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHIT:AY44]"P% &IHNBOJCO-*X@L(/FGN&Z*/0>I/I71:.NEZOJ36]
MCX:CFLX2 \K2MYFT\;B,XSQ4^O:EH.GL-!FTVY:"U"MB*;8KLRALGU//>L3[
M=X3_ .@->_\ @37$W*HKV?E_5T=*48.UUY_U8VO$WAKQ!?7P@MK5#IT Q;1Q
M, JCZ'OZU#HG@6\C>2[U2T+K",QVRL,S-V!/85E_;_"?_0'O?_ FC[?X3_Z
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MT_\ P'^M:-=U'X$>/B?XK"BBBM3G"BBB@ HHHH **** "BBB@ HHHH ****
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M*O2D?I7&>L3Z7]Z?_@/]:T:SM+^]/_P'^M:-=U'X$>/B?XK"BBBM3G"BBB@
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M[W&/N_K77?\ "K/^HS_Y*_\ V==%/$4X1Y9/4\?$49RJ-I'G5%>B_P#"K/\
MJ,_^2O\ ]G1_PJS_ *C/_DK_ /9U?UNCW,/J]3L>=45Z+_PJS_J,_P#DK_\
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M_J,_^2O_ -G1_P *L_ZC/_DK_P#9T?6Z/</J]3L>=45Z+_PJS_J,_P#DK_\
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M_J,_^2O_ -G1_P *L_ZC/_DK_P#9T?6Z/</J]3L>=45Z+_PJS_J,_P#DK_\
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MJBO1?^%6?]1G_P E?_LZ/^%6?]1G_P E?_LZ/K='N'U>IV/.J*]%_P"%6?\
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M:W_VP_\ :E>HUPU/B9SRW"BBBLR0HHHH **** "BBB@ HHHH **** "BBB@
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M7D?QN^]H/_;Q_P"TZ]<KR/XW_>T'_MX_]IUK1^-"9Y6G2GTQ.E/KTR0HHHH
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M 964Y!!Z$4Z@ HHHH **** "BBB@ HHHH **** "BBB@ KR/XW_>T'_MX_\
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M>6.M+-XAUVTO+#RV!BB)W;NQ_P!6O\Z[FJ?02ZA1112&%%%% !1110 4444
M%%%% !1110 4444 %>)_%[_D<+3_ *\$_P#1DE>V5XG\7_\ D<+3_KP3_P!&
M25M1^,:.(7I2/TI5Z4C]*[BCTWX+_>UW_MW_ /:E>KUY1\%_O:[_ -N__M2O
M5ZX*OQLEA11160@HHHH **** "BBB@ HHHH **** "J&MZ5#KFBWFF7!*Q7,
M9C++U7T(^AP:OUFZ]I1US0[O31>36GVA"GG0XW#_ .L>A'''>E)70UN>6VOA
MWXE>!XC!HEQ;ZEIJ,66'Y3QU^ZV&'T4FNQ^'_CIO&%M=17=H+74+,@3(N=K9
MSR >1R",'/UKG8O"?Q/TN$6.G>*;.2S7Y4:?EPO_  *-B/H"<5TO@+P0/!]G
M<O<77VK4+Q@T\HSMXS@#/)Y).3UJEUO_ ,$E^1QWQ6_Y*!X4_P!]/_1HKUC4
M+V'3=.N;ZX;;#;Q-*Y]@,FN+\;>"=2\2>*-$U.SGM$@L&4RK,[!CAPWRX4CH
M.Y%:WCW0]7\1^&GTK29K:%IW7SGN'91L'.!M4]2!^%9JZ@TM[LO1SN]K(\B\
M+0Z1XIN/$VJ^(M3L+6XO$:.V6YN40J[<[@&.<+A0#]:ZWX)Z[YNFWOA^9P9;
M1S+#A@048_-CU ;G_@5:^E_"'PO!I=M%J-A]HO5C GE6XE 9^Y ##C/M52Q^
M&MWX>\?VVL^'I+6'2E 66VEFD+[2,,!\ISV(R>M:JR=NEK?=U(=VK];W*/Q2
MTFYT'5+/QQHS"*YA=8[D8X;LK$=\CY3^%:?PG\-M::3)XCOV\W4M5S)YC<E8
MR<]?5CR?P]*Z'QYX>N_%'A2?2[*2".>21&#3L0N%;)Z G]*T/#6F3:-X9T[3
M;AHVFMH%B=HR2I(';(!Q^%3#1/\ #Y[CEJU_6VQJUY#X+_Y+CXF_ZYS?^C$K
MUZN$\/\ @O4M)^(VL>(IY[5K.]218TC=C(-S*1D%0/X3W-$?COY,;^%KT/,-
M'\'KXOU3Q?#$=M];3F2U8G +>8^5/L?T.*A\0^,9]8\!0Z%JH==7TZ]56\P?
M-(@5AD_[0/!_ ^M>K>!_!>H^&O$&NW]Y-:R1:A)NB$+L64;V/S94=B.F:S/B
M%\+9/$^IQZGH\MK;7;C;<K.659,=&!4'GMTY_G"348KR7WH=_>;\W]QS_P 6
M,_\ "&>$L=?*'_HM*TEO?C'M&-,M,8X^:#_XNM?QOX"U3Q+H&A6%G<6<<M@@
M64S.P4_*H^7"GT[XKT-1A0/05J]Y/S9G'X8KR1XK\66OVL_")UI2B%<WJIC
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MB^(2:TI\27%J^G^6V1$(\[NW0 US2_#KQQIOB#5-2T36=-M!>SNY^=BQ4N6
M.8R,\]JW= T+XBVNN6L^L>(K*YT]&)FAC)W,,'I^['?'>E#:*\ARW;\S$\*_
M\EX\0_\ 7*3^:5T/Q?%D?A_<FZV><)8_LV>N_<,X_P" [OPK#U+X?>,4\::E
MKVA:MI]F;ICM+NV_8<<$>61VJ6U^%>JZOJ$5YXR\0/J"Q'(MH68J?;<<;1Z@
M*,^M2E>$8O2W^93=IN7];'5?#C[1_P *^T;[3G?Y'&?[FX[?_'<5U--BC2&)
M(HD5(T4*JJ,!0.@%.K23NVS.*LK!1114E!1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O$_B__ ,CA:?\ 7@G_ *,DKVRO$_B__P CA:?]
M>"?^C)*VH_&-'$+TI'Z4J]*1^E=Y1Z;\%_O:[_V[_P#M2O5Z\H^"_P![7?\
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M=[K<,X3;97QMXMHQ\H13SZG)-'E_7]:@;E%<=?\ BR[TZ7Q:Y@2:/2(X7@0
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M)84445D(BEE975$0,[ G!.!@8[_B*3==?\\8?^_I_P#B:&_X_8O^N;_S6IJ
M(=UU_P \8?\ OZ?_ (FC==?\\8?^_I_^)J:B@"'==?\ /&'_ +^G_P")HW77
M_/&'_OZ?_B:FHH AW77_ #QA_P"_I_\ B:-UU_SQA_[^G_XFIJ* (=UU_P \
M8?\ OZ?_ (FC==?\\8?^_I_^)J:B@"'==?\ /&'_ +^G_P")HW77_/&'_OZ?
M_B:FHH AW77_ #QA_P"_I_\ B:-UU_SQA_[^G_XFIJ* (=UU_P \8?\ OZ?_
M (FC==?\\8?^_I_^)J:B@"'==?\ /&'_ +^G_P")HW77_/&'_OZ?_B:FHH A
MW77_ #QA_P"_I_\ B:-UU_SQA_[^G_XFIJ* (=UU_P \8?\ OZ?_ (FC==?\
M\8?^_I_^)J:B@"'==?\ /&'_ +^G_P")HW77_/&'_OZ?_B:FHH AW77_ #QA
M_P"_I_\ B:-UU_SQA_[^G_XFIJ* (=UU_P \8?\ OZ?_ (FC==?\\8?^_I_^
M)J:B@"'==?\ /&'_ +^G_P")HW77_/&'_OZ?_B:FHH AW77_ #QA_P"_I_\
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MA,\K3I3Z8G2GUZ9(4444""DHHH ***2F 4444 %)110(**** "BBB@ I***
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MNI#.+:%I74-&R@[5!)&:ZJBA]/(._F<WI-O-_P )OKMXUO*D,UM:"*1XRH;
M?(!(ZC(R.U<K=:'J?]EQW<,%_']BURZN6BMD43&)F8!XU<$,1G(XY!.*].HI
M6_KYW'?^OE8XWPW:1W>OMJ1G\1S26\!A634X$A1@Y!*@;%8D%1VQ6MXOTJ36
M?"U]:09^TA/-MR.HE0[EQ^(%;E%-ZJPEH[G Z5H-]K?@;5Y=3MWMM5UAWN#&
MZE6A9<"(8/(QM4_C4GA6RU*X\-:WJ^J6<L.J:KO+0,A#JJ)L1<'GL3^-=U12
MDKIKNK M+>3N<)X<^'WAV3PQIKZAH$(O6MD,WFHROOVC.0>AS5+0M+OH(? 2
MO8W,?V5KKSPT3#R048#=Q\N>,9KTBBKOK?\ KK_F)+2QS.O6MQ-XP\+3Q02O
M#!+<&614)6,&(@;CVR>.:Q_'UG!/X@T&>^T.^U;3XDN!-%:VS3$$A=N0.G/\
MJ[ZBI[%7..\'OHL5[<0:3X6U32#)'NDENK)H4?:>!DD\_,>/K4/BRY>S\=>%
M[E;.6[\N.Z+1Q+N<#:H+*.Y'H.3VKMZJ3:;:7&HVNH2Q;KJU5UADW$;0X ;C
M.#G ZT[ZI]O^"+H_Z['(-]IU_P 07VK6^FWEM:0:5+:*US T4EQ(Q#85#\V!
MCJ1U-!T2^G^%^CVD%H?M5JEM.]G(-AD*%6:,@]"<'KWKNJ*7I_5G?\P_K\+'
M%7]Y-XKO-'MK/2=1MA:WD=Y/<7MLT(A"9.T;OO,>GRY&">:H:YINHZIXC;Q%
M;:43!I+J@M98F634-I)9@#C.W/R9!R<^U>B44>@>IQ7C&ZDTJ/3_ !=8VTCS
M0J;>6%E*/)'+]U2#R")-AQ]:W_#.E-HWA^ULY6WW 4R7#_WY6.YS_P!]$U)>
M:%I^H:A!?744DLL!#1JTS^6&&2&\O.TD9/)&:TJ%HG_7]:@^AQ[RS>'/%^JW
M]SI][=6FI)$8KBT@:8Q%%VF-E7+ =P<8YJ+6M0O[RZTJ:6#7+'1YHG:9;2%C
M.)<C8)!'N95(R>.^,UVM%'8#RBXTS49O#WC=([#57^U-;FV6ZB+2S *H)  Y
MZ?4=^:ZWQ7:7,8T34K6RDNX],NA++:PKERA0KE5[E<Y KJJ*/^!^ ?\ !_'_
M (8XDW4VM>.]"OH-)OX;.WAN4>YN+9HN65< @C('H3C)SC.*T_'EG<W_ (+U
M"WM(7GGPCK'&,LP5U8@#N< \5T=%'16_K6X+>_\ 78XR_N93K6D>*(=-O[BR
MC@EMI8?LS"> LRXD$9 8CY<' S@YYJQI*W&K^,IM>6QN+.RCLOLB&YC,<EPQ
M?=NV'D*N,#(YR:ZNBA:?C^(?U]QR'B[1$UOQ%X:ANK!KNP66<W V$HH\H[=Q
M'3D#&>]6;CP)H:Z+J5AIMC#9-?6YA:2,'\"?H>:Z:BE;2P[ZW./L_%5]86$=
MGJ?A[5FU.%1&1:6QEBF(XW)(/E /7YB,9J@?"VKG1/[2\N+^W?[4_M;[-YGR
M9QM\G=_N<9Z9]J[^BFWK?J)+2W0YF'Q?)<RP6\/AS6_M,CA9$EM?+2(9Y)D8
M[2 ,XP3FJ4%S<>%/$&L?:M-OKFQU&X^UP7%G TVUMH5D=5Y!RO!Q@YKLZ*/,
M/(XS2$U)!X@\12Z-,SZB\?DZ<Y593$B[<MDX!(R=OX5B?8;*;6=.N?"WA_5M
M(U$W*-<NUJ]M L(/SK(#\C9'0+GGO7IU%"W3[ ]4SGO'5M/=^"-7M[:"2>:2
M A(XD+,QR. !R:Y/2O\ A&+2]M);?P#KL%TCKMF.F. C?WB<\"O3:*%H[@]5
M8XC7-&NO'&I3V-P+FPTG3R?*D*%'GN<<.,]43/7N?:J>ORZOJ_P[U"QU#2KI
M]2MIHHIDA@9EN0)%.^/'W@5YXZ<YQ7H=%'2W]?UT]!];_P!?U^IYSHS>&;76
M;22Q\":W9W/F!4N'TUT6/=QDDG@8/)]*70/$,WAZ+4+*Z\.>(97.HW,JR6^G
M,Z,K2$@@\9XKT6B@FQ#:7'VNSAN!%+#YJ!_+F3:Z9&<,.Q'<5-110,**** "
MO$_B_P#\CA:?]>"?^C)*]LKQ/XO_ /(X6G_7@G_HR2MJ/QC1PZ]*1^E*O2D?
MI7>,].^"WWM=_P"W?_VI7J]>4?!;[VN_]N__ +4KU>O/J_&Q,****R$0M_Q^
MQ?\ 7-_YK4U0M_Q^Q?\ 7-_YK4U !5<W$IFD2. ,$(!)?';/I[U8K.EB87<S
M-9SRAR"K1R*!T [L* +;W4,6!-+'&^ 2I8<4AO(%NDMS(OF,NX#(YID,3_;)
M)6C*JT** Q!((+9'7W%16T,T/V/=$QVP>6^"/E/'7GV/2F!:%S TOE"5#)TV
M[N<TY)HI&*I(K,.H!SBLZ"TF3RX9#<E4;.X&/8<'.>FZKMI$8;?:R[3O9B/J
MQ-("7S$PYWKA/O<]._-,>Z@B(#S(I(R,MV]:J72%KP0H05G'[T9Z!>^/<''Y
M4\K+#-/BW,RS'((*@#@#!R>G';/6@"V'4N4##< "1GD _P#ZJ8;B$!"94^?!
M7YOO?2JD,$UG(N(VFS"D9*D#!7/7)Z<_I3K.VDB^S&1 &2W"'D'!XR/TI@6Y
M)HH0#+(J ]-QQFF_:(?*$OFIY9.-V>,^E,FB9[JV<+E49BQ]/E(J%X[A/,**
M^UIMQ$9 8KM'3/O2 L_:H!&)#-&$)P&+#&?3ZTT7ELQ4">,EN -PYJG%;3F5
M7:-@/M/F?.P)"^7CM[U*UM(8KP!.9)0R\CGA>?TI@66N8$E$;2H'./E+<\]*
MEK,DM9O,GC)N&CE8G,9CVX/KGGC\:TQP*0!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4*_\
M'[+_ -<T_FU35"O_ !^R_P#7-/YM0!-1110 5Y%\</O:#_V\?^TZ]=KR+XX?
M>T'_ +>/_:=:T?C0F>5ITI],3I3Z],@*2BB@ HHHI@%)110 4E%% !1110(*
M*** "DHHH **** "BBDIB"BBB@ HHHH *2EI* "BBDH$%%%% !1110 4E%%
M'54E%%<QZ8444E !1110 4444""DHHH **** "BBBF 4E%% !1110(***2@
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MHHK(1"W_ !^Q?]<W_FM357F=8KF*1V"IL9=QX )*_P"!IWVRU_Y^8?\ OL4
M345#]LM?^?F'_OL4?;+7_GYA_P"^Q0!-14/VRU_Y^8?^^Q1]LM?^?F'_ +[%
M $U%0_;+7_GYA_[[%'VRU_Y^8?\ OL4 2A0&+ #)ZG%+4/VRU_Y^8?\ OL4?
M;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\
MOL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^
M8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VR
MU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-1
M4/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q
M0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8
M?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_
M )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?
M;+7_ )^8?^^Q0!-14/VRU_Y^8?\ OL4?;+7_ )^8?^^Q0!-14/VRU_Y^8?\
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MM _[>/\ VG7KM>1?'#[V@?\ ;Q_[3K6C\:$]CRI*?3$I]>FB I***8!1124
M%%%% @HHHH ***2@ HHHH ****8@I*** "BBB@ HHI* "BBB@04E%% !1110
M 444E !1110 4444".II***YCU HHHH ***2@04444 %%%%, HHI* "BBB@
MHHHH$%)110 4E+24 %%%% !1124""BBB@ HHHI@%%%)0 4444 )4<G2I*CDZ
M4A'H_P '?O:W_P!L/_:E>I5Y;\'?O:W_ -L/_:E>I5PU?B9C+<****S)"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\2^,'_(XVG_7@G_HR2O;:\2^,'_(XVG_ %X)_P"C)*VH
M_&-'#KTI'Z4J]*1^E=XST[X+?>UW_MW_ /:E>L5Y/\%OO:[_ -N__M2O6*\^
MK\;)84445D! _-[%GM&Y_5:GJ%O^/V+_ *YO_-:FH ***C:>%&VO*BGT+ 4
M244@(8 @@@]"*6@ HHHH **** "BBB@ HHHH **** "BFB1"VT.I.<8SW]*=
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC:0H&:/&5++R,\C(Z'FEW^7_  1]5\RUI_B1KC4HK#4-)O-,GG1GM_M!1EE
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MQSFE/9V\_P#@?U_D5'=7\O\ @FK+XF-G'IMC!97.I:I<6JSF" J"$P,NS,0
M,\>YJCI/B@2Z]XDFOGGM+/3[>W9X+@8,#8<OTR#G Y!(/&*)-/U?1]:LM8LM
M.-^KZ?'975LDJ))&4.0REB%(Y((SZ&J;^&]8UU_%7]HVT=B-5M8$ML2!]A0-
MPQ7N#MSVYP"<9JI;MKS_ #T_ F&R3\O^";5IXM,MQ:"\T;4+"VO7"6US<!-K
ML1E0P5BR$]LBG6?BR._U6[L+;3;QS9W+07,^%$<8 !W$D\YST )XYQ6#IGAZ
M2>]LHK_PO>Q>3());B;6Y)8E9>59$\PEN0" 0,=ZWO#>FWNG2>('N( INM2E
MN( 7&'0JH!XSCD'KS[4G_G^@+_+]1=(\42ZR]O+!HE^NGW.?)O6,6Q@,\E0^
MY0<<9'I5_6M8BT.TBN[B*1H&G2*1TQB(,<!FSV!(S]:Y'3M&U*'7[*?3]!GT
M)1.7O]M\KVTR8.0L8;J3C!VKBNUU/3X=6TNZT^X&8;B)HV^A&,T/:Z!;V97N
M]:@M-:L]+*.\US'),6!&V*-,99O8D@"L?_A.8C;'4ET?46T4'G40J;-N<;]F
M[?L[[MO2J_AKP]JDEOJ,_B,*M[/;KIZ,CAOW"+C>".A9B6Q]*@2#Q/'X8_X1
M<:+$7$'V-=1\]/(\K;MWE,[\X_AQU[XH>FW]?TK?T@7G_7]._P!WF6KOQ+J<
M?CVTTVUL)KC3Y;,RYC:+#_,O[P$MG:H)!'4]@:NW7BPI>W5OIVCW^II9-MNI
M;?8%1L9*KN8%V'<#UJG-I%_I'B/1+NRLI+^TMM/-A(4D163E,.0Q&1A3TYK(
MG\+W6FZKJ9&B7NJ0W=P]S!+::L]MM+\E'7S%'!S\P!XH]//\]/P!=WY?EK^)
MWNGWUOJ>GP7UI)OMYT#HV,9!]NU6:H:+I\6EZ/;6<-L+9(TR81*TH1CR1N;E
MN2>35^F]]!+8****0PHHHH *\2^,'_(XVG_7@G_HR2O;:\2^,'_(XVG_ %X)
M_P"C)*VH_&-'#KTI'Z4+TI'Z5WC/3_@K][7?^W?_ -J5ZQ7D_P %?O:[_P!N
M_P#[4KUBO/J_&R0HHHK("%O^/V+_ *YO_-:FJ.2(2%6#,C+T9<9_6F^1)_S]
M3?DG_P 30!-14/D2?\_4WY)_\31Y$G_/U-^2?_$T 345#Y$G_/U-^2?_ !-'
MD2?\_4WY)_\ $T 345#Y$G_/U-^2?_$T>1)_S]3?DG_Q- $U%0^1)_S]3?DG
M_P 31Y$G_/U-^2?_ !- $U%0^1)_S]3?DG_Q-'D2?\_4WY)_\30!-14/D2?\
M_4WY)_\ $T>1)_S]3?DG_P 30!-14/D2?\_4WY)_\31Y$G_/U-^2?_$T 345
M#Y$G_/U-^2?_ !-'D2?\_4WY)_\ $T 345#Y$G_/U-^2?_$T>1)_S]3?DG_Q
M- $U%0^1)_S]3?DG_P 31Y$G_/U-^2?_ !- $U%0^1)_S]3?DG_Q-'D2?\_4
MWY)_\30!-14/D2?\_4WY)_\ $T>1)_S]3?DG_P 30!-14/D2?\_4WY)_\31Y
M$G_/U-^2?_$T 345#Y$G_/U-^2?_ !-'D2?\_4WY)_\ $T 345#Y$G_/U-^2
M?_$T>1)_S]3?DG_Q- $U%0^1)_S]3?DG_P 31Y$G_/U-^2?_ !- $U%0^1)_
MS]3?DG_Q-'D2?\_4WY)_\30!-14/D2?\_4WY)_\ $T>1)_S]3?DG_P 30!-1
M4/D2?\_4WY)_\31Y$G_/U-^2?_$T 345#Y$G_/U-^2?_ !-'D2?\_4WY)_\
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MO!/_ $9)6U'XQHX9>E(_2E7I2/TKO&>G_!7[VN_]N_\ [4KUBO)_@K][7?\
MMW_]J5ZQ7GU?C9(4445D 45QOC[7]1T1+!=/F$)F,A=MBL?EVX'(/]ZN*_X3
MOQ)_T$O_ "!'_P#$UUT\).I'F31SSQ$82Y6>ST5XQ_PG?B3_ *"7_D"/_P")
MH_X3OQ)_T$O_ "!'_P#$UI]1J=T1]:AV9[/17C'_  G?B3_H)?\ D"/_ .)H
M_P"$[\2?]!+_ ,@1_P#Q-'U&IW0?6H=F>ST5XQ_PG?B3_H)?^0(__B:/^$[\
M2?\ 02_\@1__ !-'U&IW0?6H=F>ST5XQ_P )WXD_Z"7_ ) C_P#B:/\ A._$
MG_02_P#($?\ \31]1J=T'UJ'9GL]%>,?\)WXD_Z"7_D"/_XFC_A._$G_ $$O
M_($?_P 31]1J=T'UJ'9GL]%>,?\ "=^)/^@E_P"0(_\ XFC_ (3OQ)_T$O\
MR!'_ /$T?4:G=!]:AV9[/17C'_"=^)/^@E_Y C_^)H_X3OQ)_P!!+_R!'_\
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MPF,)C*-L53\V[(X _NUG4PDZ<>9M%PQ$9RY4=E1117(= 5Y#\<?O:!_V\?\
MM.O7J\A^./WM _[>/_:=:T?C0GL>4KTI],7I3Z]1&84444 %)2TE !1110 4
M444Q"4444 %%%% !1124 %%%)0(**** "BBB@ HHI* "BBB@ HHHH$%)110
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MJBO1?^%6?]1G_P E?_LZ/^%6?]1G_P E?_LZ/K='N'U>IV/.J*]%_P"%6?\
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MB@ HHHH **** "DHHH$%1OTJ2HWZ4 >D?!O[VN?]L/\ VI7J=>6?!O[VN?\
M;#_VI7J=<%7XV92W"BBBLR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 =31117,>F%%%)0 4444 )1110 4444 %)110(****8!1110 4E%%
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MSE5XXZ8_&L3PS8QZAXSU"]L;J.YT2QD>6R*<H+B909-K="!@].F\UZ'0  ,
M8%'6X=+%/2_[1_LZ+^UOLOVWGS/LN[R^IQC=STQ^-7*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O$?C#_P CC:?]>"?^C)*]NKQ#
MXP_\CC:?]>"?^C)*VH?&!PR]*1^E*O2D?I7>,]0^"GWM=_[=_P#VI7K->3?!
M3[VN_P#;O_[4KUFO/J_&Q!11160!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>0_'+[V@?]O'_
M +3KUZO(/CE][0/^WC_VG6M'XT)['E*=*?3$Z4ZO41F%%%%,04444 %)2TE
M!1124""BBB@ HHHH *2EI* "BBB@ HHHH$%)110 444E !1110 4E+24P"BB
MB@04444 %)2TE '5444E<QZ84444 %)110 4444 %)2TE @HHHH ****8!24
MM)0 444E !1110(*2EI* "BBB@ HHHH ***2@ HHHH$%%%% !44G2I*CDZ4
M>D_!O[VN?]L/_:E>IUY7\&_O:Y_VP_\ :E>J5P5?C9C+<****S$%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQP*=3;;U8DDM$%%-26.0L$=6*':VTYVGT/O3J0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "O$/C%_R.-I_P!>"?\ HR2O
M;Z\0^,7_ ".-I_UX)_Z,DK:A\8'"KTI'Z4J]*1^E>@!ZA\$_O:]_V[_^U*]:
MKR7X)_>U[_MW_P#:E>M5YU7XV 4445D 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D'QR^]H'
M_;Q_[2KU^O(/CG][0/\ MX_]I5M1^-">QY.O2GTQ>E/KTT9!1124Q!1110 4
M444 %)110 4444 %%%% A**** "DHHH ****8!2444""BBB@ HHHH *2BB@
MHHHH ***2@04444 =31117,>H%)110(****8!1110 4E%% !1124 %%%% @I
M*** "BBB@ HHHH *2BB@04444 %%%% !2444 %%%% !2444Q!4;]*?4;]*0'
MI7P:^]KG_;#_ -J5ZI7E?P:^]KG_ &P_]J5ZI7!5^-F4MPHHHK,04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!QNH>(=0C\17-B=1L-+$9
M46R7MNQ6Z! )/F;@!SQ@<THCU27QOK,>G7%M;DVUL9)I8C)@_/@!<CKSR3QC
MH<U?UC0-4U5;JU.LH+"YX:&2S5V0=PK9'YD$BKVGZ*NGZK=WJ3EEG@AA$97E
M1&&&<YYSN].U=BG3C#2U[?Y?UU_0YG&;DUTNOU,B+Q'<MX:DN;NZLK"\ANFM
M9))(VD1F5L$HH())'(&:IVOBN[":O;-=07DUI9-=PW"V[0YQD%71CP0<?4&M
M%_"<BHDEMJ CNXK^2]BD:#<HWY!4KGG@]<BD?PK=75Y?7=YJHEFN[!K,A+;:
ML>3G*C<3@>A)^O:FG1L[_P!;?\'J%JEU_6EW_P  KOXAU33?"JZYJ+6A:XCB
M%O;HI549\?,[D].<G &,=^M0Z9XL?^VK*RFUG3-32\)3_1$*-"^"1_$=RG&,
M\'I6]/H,-UX;AT>:9\0Q1HDZ#:RL@&UQZ'(S1IUAK,%TLE_K274*H5$4=HL6
MX_WF.3S],4N>DU+3O]W2PE&K[NO1??U.4TBXUZQ\(SZC9RV0MK2:XD%O)$6:
M91*Y;+;AM[@#!Z>];LNKZCJVI)I^D-!:A;9+FXN)XS(4W_=55!&3P<DFK5OX
M>^S^&+G1OM6[SA,/.\O&/,9FZ9[;O7G%13>'+B*>VN],U'[)>16ZVTK-#YD<
MR+TW+D8(/0@^U.52G*3;MY:>2W^?]6&H32T_K5[?+^KF)K>IWEQHFJZ9J*Q?
M;+*>V)EA!"2H\@*L <X/!!&36O+J&KZGKU[8:7/;6D%@$$LTT)E,CL,[0 PP
M ,9-(WA(S:;>1W&H-+?7LL<D]TT0YV,"JJH/"@#'7O4]WH-X-8FU+2=3%E)<
MHJW$<D'FHY7A6 R,$#CWHYZ>RM^E[+_@V#EGO_P]KLYVSUZXT/2?$%[<Q0+>
M-JWDA2Y$0<H@W$]0O?Z5=TKQ6YUNTL)M8TW4TO-P!M$*-"X&[!&XY4X(SP<X
MJ[!X/C32[^SGOYII+J[^V+<;0KQR +@CL3E<]NN*T-.L-9ANA)J&LI=1*A41
M1VBQ!C_>8Y)S[# ISG2:D^O_  %:WS)4:B:[?\%[_(QM'UGQ!J&ASZNR6SI$
MLXBMHHR7G968#G/R] , $G'O4WAC6;K59LR:QI]T/+W2VJ6[0S0/QQ@L20.1
MDCTK1TO1)=*\/'3(;YA+F1EN5C *EG+?=.1QFJ]IX?O?[;M]4U/4HKJ6VC:.
M(16HASNX)8[CGCMP*F4J3YK67;^O^&?R+Y9JW]=?\OZN=!1117&= 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XA\8O^1QM/^O!/_1DE
M>WUXA\8O^1RM/^O!/_1DE;4/C X5>E(_2E7I2/TKT /4/@G][7O^W?\ ]J5Z
MU7DOP3^]KW_;O_[4KUJO.J_&P"BBBL@"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@^.?WM _
M[>/_ &E7K]>0?'/[V@?]O'_M*M:/QH4MCR=>E/IB]*=7J(R"BBBF(**** "D
MI:2@ HHHH ****!!2444 %)2TE !1110 4E+24P"BBB@04444 %)2TE !111
M0 444E @HHHH ***2@#JJ2EI*YCTPHHHI@%%%% !24M)0 444E !1110(*2E
MI* "BBB@ HHHH *2EI* "BBB@04444 %)2TE !1110 4E%%,0444E !4;]*D
MJ-^E 'I7P:^]KG_;#_VI7JE>5_!K[VN?]L/_ &I7JE>?5^-F3W"BBBLQ!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>'_&+_D<K3_KP3_T9)7N%>'_ !B_Y'*T_P"O!/\ T9)6
MU#XP.%7I2/TI5Z4C]*] #U'X)_>U[_MW_P#:E>M5Y+\$_O:]_P!N_P#[4KUJ
MO.J_&P"BBBL@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME>5_!L?-KG_;#_VI7JE>?5^-F3W"BBBLQ!1110 4444 %%%% !1110 4444
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M "BBB@ IK#BG4E '1>!_%2>%M4F:XC9[.Y4++L&64@G##UQD\>]>G#XD^$\
MG52/8VTO_P 37AI7-1F,5C*DI.Y+5SW;_A9/A+_H+?\ DM+_ /$T?\+)\)?]
M!;_R6E_^)KPCRO:CRAZ5/L(BY3W?_A97A+_H+?\ DM+_ /$T?\+*\)?]!;_R
M6E_^)KPCRAZ4>4*/81#E/=_^%E>$O^@M_P"2TO\ \31_PLKPE_T%O_):7_XF
MO"/*%)Y0H]A$.4]X_P"%E>$?^@M_Y+2__$T?\+*\(_\ 06_\EI?_ (FO!_*%
M'E"CV$0Y3WC_ (65X1_Z"W_DM+_\11_PLKPC_P!!;_R6E_\ B*\'\H4>4*/8
M1#E/>/\ A97A'_H+?^2TO_Q%)_PLKPC_ -!;_P EI?\ XBO!_*%'E"CV$1<I
M[Q_PLKPC_P!!;_R6E_\ B*/^%E>$?^@M_P"2TO\ \17@_E"CRA1["(6/>/\
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MA#_H+_\ DM-_\11_PLWPA_T%_P#R6F_^(KP'RQ1Y8H^KQ$>_?\+-\(?]!?\
M\EIO_B*/^%F^$/\ H+_^2TW_ ,17@/E"CRQ1]7B![]_PLWPA_P!!?_R6F_\
MB*/^%F^#_P#H+_\ DM-_\17@/EBD\L4?5X@>_P#_  LWP?\ ]!?_ ,EIO_B*
M/^%F^#_^@O\ ^2TW_P 17@'E"CRA1]7B![__ ,+-\'_]!?\ \EIO_B*/^%G>
M#_\ H+_^2TW_ ,17@'EBCRQ1]7B![_\ \+.\'_\ 07_\EIO_ (BC_A9O@_\
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M_P"%H^#?^@Q_Y*S?_$4?\+1\&_\ 08_\E9O_ (BOGCR_:CR_:CZM$7,?0_\
MPM'P;_T&/_)6;_XBC_A:/@W_ *#'_DK-_P#$5\\>71Y='U:(<Q]#?\+1\&_]
M!C_R5F_^(H_X6CX-_P"@Q_Y*S?\ Q%?//E^U)Y?M1]6B',?0_P#PM'P;_P!!
MC_R5F_\ B*/^%H^#?^@Q_P"2LW_Q%?/'E^U'E^U'U:(<Q]#_ /"TO!O_ $&/
M_)6;_P"(H_X6EX-_Z#'_ )*S?_$5\\>71Y=/ZM$.8^A_^%I>#?\ H,?^2LW_
M ,11_P +2\&_]!C_ ,E9O_B*^=_+H\NCZM$.8^B/^%I>#?\ H,?^2LW_ ,11
M_P +2\&?]!C_ ,E9O_B*^=_+HV4?5HAS'T1_PM+P9_T&/_)6;_XBC_A:7@S_
M *#'_DK-_P#$5\[;*/+]J/JT0YCZ)_X6EX,_Z#'_ )*S?_$4?\+2\&?]!C_R
M5F_^(KYV\NCR_:CZM$7,?1/_  M+P9_T&/\ R5F_^(H_X6EX,_Z#'_DK-_\
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M@ Q28I:* $Q1BBB@0E&*** #%&*** $Q1BEHH 3%&*** #%&***8A,48I:*
M$Q1BBB@ Q28I:* $Q1110 444E @HHHH ,4F*6B@!,48HHH ,48HHI@&*3%+
M10(3%&*** $Q1BBB@ Q28I:* $Q1BBB@ Q1BBB@08I,4M% "8HQ110 8HQ11
M0 F*,4M% A,48HHH ,4F*6DI@&*,444 )BC%%% @Q1BBB@ Q28I:* $Q1BBB
M@ Q1BBB@ Q28I:2F(,48HHH ,4F*6B@!,48HHH 3%&*6DH$&*,444 %%%% !
M2444 %%%% !1124""BBB@ I*** "BBBF 4E%% @HHHH **** "DHHH ****
M"BBDH$%%%% !1124 %%%%, I*** "BBB@1U5)117,>H%%%)0 4444""DHHH
M**** "BBB@ I*** "BBB@04444 %)110 4444 )1113$%)110 4444 %%%%
M!2444 %%%% @HHI* "BBB@ I***8!1110 4E%% @HHHH **** "DHHH ****
M "BBB@04E%% !24M)0 4444 %)110 4444Q!1110 4E%% !1110 4E%% @HH
MI* "BBB@ HHHH *2BB@ HHHIB"BBB@ I*** "BBB@ HHI* "BBDH$%%%% !1
M110 4E%% !1113 ****!!2444 %%%)0 4444 %)110 4444""BBB@ I*** "
MBBB@ HHHH$%)110 4444 )1113 *2BB@ HHHH$%%%% !2444 %%%% !1124Q
M!1110 4444 %)110 444E @HHHH **** "DHHH **** "BBB@04E%% !24M)
M0 4444 %)113 ****!!1110 4E%% !1110 444E @HHHH ***2@ HHHI@%)1
M10 4444""BBB@#J:**2N8]0****!!24M)0 4444 %%%% !24M)0 4444""BB
MB@ I*6DH **** "DHHIB"BBDH **** "BBB@ I*6DH ****!!1124 %%%% !
M2444P"BBB@ I*6DH$%%%% !1110 4E+24 %%%% !14UI;F[O8+8-M,TBQACV
MR<5U\?PZN9/$4^CC4(@\5NL_F&,X.3C&,U+DH[DMI'%4E=%I/A&\U'Q)-H<T
MBVMQ"K,Q921QCI['.<TK^$9O^$;NM8@NTF%K,T4T*H=RX;&<_0@_0TN>/<?6
MQSE%;^D^%Y=2T"_UF2Z2VM;3/WER9#C.!^8'XUK1> (1IME>7GB*PLQ=PK*B
M3X4X(!P,D9QD4W-+<5SB:*ZR'P/)>ZX;#3]5LKJ".$337<; QQC)&#@GGCI2
M:EX+BL[1+RUU_3KRT,RPR2(X!0L<=,D<=>O2ESQ"YRE)7?1?#>">UDNHO$^G
M26\7^LE0@HGU.[ K)M?!5SJ.NSZ?IM[:W5O JM)>JW[H C/49R>O'M0JD7U#
MI<Y>BNRO_A]/'I\UYI.J6FJI!_KDMR-RXZ\ G/TZU'HW@==4T"/5Y]9M;&!W
M*?OQ@ @XZD@4>TC:]P.1HKH/$?A&]\.QPW#S0W5G.<1W$+9!/7!_#ZU4T#P]
M?^([_P"R6*+\HW22.<)&/4FJ4DU= ]#*HKL=3\!?8],N+VRUS3[X6HS<(CA2
MGMU//L<4S2_ 4]UI<>I:GJ=II5K, 8C<$9?/0X) &?K2]I&U[@<A170ZWX0O
M]"O;6*=XY;>Z8+#<Q'*-G^1YS3O%7@Z]\+20F:19[>8869%( ;^Z?>A3B[:[
MAUL<Y25V%QX&2RUJ+3[S6[.V62U^TB>;Y%^]C;R>O?\ "KEW\.;>RMXYKCQ/
MIL:2H7A+D*)!C.5);GJ.GK0ZD4!P=%=-X4\%W7BI+F2*X2WB@(7>ZD[F/8?Y
M[UAC3;MM4.FI"SW?FF'RUZE@<8JN97Y>HKZ7*E%=ZOPRE&VVFUW3HM49=RV9
M;D_CG/Z52TCP+'J@\I_$&G07GFO']EWJ[DJ2.,-SG&:CVD>X''T5T_B3PE!X
M>MBW]N65W<+*(WMHR/,7@G)&<CI^M<Q51DI*Z'8***2J$%%%% !1113$%%%)
M0 4444 %%%)0 4444""DHHH **** "BBDH ****8!1110(*2BB@ HHI* "BB
MB@ HHI* "BBB@04444 %%%=+X9\&77BC3[^YM+A$DM0,1,O,A() ![=*3:BK
ML/(YFBM[PQX6O/$^JO90L(!$I:61U)"=L8]2>WUK5TOX?OJ,NKB35K>UCTR<
MPR2RKA3C/S9SP.*ESBMV!QE%=;J?@ZQL;59;?Q/IE]*TJ1B&!U9OF.,X#'I6
MK<?"N2*X^QQ^(=-:^(W+;2'8Q'KC)/Z4O:Q#K8\]HKI]+\#ZC>^*)= NF%G<
MQQF0LR[@0,8(QU!SUJCI7ANYU;Q/_8D$BAQ(Z-*5X4+G+8_#]:I3B]$_,3T,
M6BMKQ1X;N/"VK_8)Y5FS&)$D48# ^WU!K.T^PN=4OX;*SB,MQ,VU$'?_ .M3
MBU)70/3<K4E>@M\+9 &MAX@TPZHJ;VL]W('USG_QVL;P_P"![[7([BZDN;>R
MT^W8I)=S."F1UVD<$>^<>]2JD7U'8Y>BNKU_P)=Z/IHU6SOK;4]-S@W%L<[>
MW(YXSZ$TFH>!+^R\)VOB".9;B":-9)(T0AHE89R?44>TCO<+,Y2BNGA\'E]!
MTG5YM2@@@U"Y^SYD&!%RPW,2<8^7]:W!\,+=K%KX>*],-FK;6N 1Y8/H6W8S
MR*<IQCN3N>>45TFF^$)-7\62Z'8W\$Z1@L;N/YHRH Y&#SR0.M4?$F@7'AK6
MI=-N'$A0!ED48#J1U'ZC\*%.+:7<=C)HKM].^&\\NG07NL:M9Z0MQCR([@C>
MV>F02,?3DU O@,0:S=:=J>OZ78M"B.DDDHVR!L],D$$8Z>XH]I&]KA;2YQU%
M=YK'PXAT6UEDN?$VG+,L)EC@?"O* #C:"W.<8K@Z<9J6P--!11259(4444 %
M%%% !1124 %%%% A**** "BBB@ HHI* "BBB@ HHHH$%)110 444E !1110
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M***!!2444 %%%% !1124 %%%% !1110(*2EI* "BBDH **** "BBDI@%%%%
M@HHHH ***2@ HHHH **** "DHHH$%%%% !2444P"BBDH **** "BBB@0444E
M !1110!U-%%)7,>F%%%% !1110 444E !1110(**** "BBDH **** "BBDI@
M%%%)0(**** "BBB@ HHI* "BBB@ HHHH$%)110 444E !1113 ***2@ HHHH
M$%%%% !1124 %%%% !1110(***2@ HHHH 2BBB@ HHI* "BBB@04444P"BBD
MH **** "BBDH ****!!2444 %%%% !1124 %%%% !1113$%%%)0 4444 %%%
M% !2444 %)2TE @HHHH **** $HHHH ****8!1124""BBB@ I*** "BBB@!*
M***!!1110 4444 )1110 4444 %%%% A**** "BBDI@%%%% "4444""BBB@
MHHHH 2BBB@ HHHIB"DHHH **** "BBB@!**** "DHHH$%%%% !1110 E%%%
M!1110(***2@ HHHH 2BBB@ HHHI@)1110(**** "BBB@!**** "BBB@ I***
M!!1110 4E%% !1113 *2BB@ HHHH$%%%% !2444 %%%% '4TE%%<QZ84444
M%%%% !2444""BBB@ HHHH *2BB@ HHI*8!1110(*2BB@ HHHH **** "DHHH
M ****!!24M)0 444E !1113 **** "DHHH$%%%% !1110 4E%% !1110 444
ME @HHHH *2BB@ HHHH *2BB@04444P"BBB@ I*** "BBDH ****!!2444 %%
M%% !1110 4E%% !1113$%%%% !2444 %%%% !2444 %%%)0(**** "BBB@ I
M*** "BBBF 4444"$HHHH *2BB@ HHHH *2BB@ HHHH$%%%% !2444 %%%% !
M1110(*2BB@ HHI*8!1110 4E%% @HHHH **** "DHHH **** "DI:2F(****
M "BBB@ I*** "DI:2@04444 %%%% !2444 %%%% @HHI* "BBB@ I*** "BB
MBF 4E%% @HHHH **** "DHHH **** "BBDH$%%%% !1124 %%%%, I*** "B
MBB@04444 %)110 4444 %)110!U-%%%<QZ84444 %)110(**** "BBB@ I**
M* "BBB@!****8@I*** "BBB@ HHHH *2BB@ HHHH$%%%)0 4444 )1113 **
M** "DHHH$%%%% !1110 4E%% !1110 4444""DHHH *ZF3P>6\"0>(K>61Y"
MS&:(CA4#%<C\AFN5KU#2M9CT?P;X::Y4-97,D]O<JPR"C,W/X<'\ZBHVH^[O
M=?J*]F<UH_@XW_A+4==N)7B2!&:!5 _>%1R3[9X_ UE6'A?6]3M?M5GIL\L'
M9P,!OIGK^%>B'5;:\TOQ/I^G$?V;IVG""#:<ACAMS9[Y(Z^V>]-T+3#9:5H,
MUC9W6H)*!++<C46BCMF)!(V X..<@CG&.]9^T>K]+?B*[1YC:Z;?7M[]BMK2
M:2Y!(,2H=PQUR.V/>MBP\(WW_"26.EZM;3V:W+$!\ YP">#T/2NZD._Q%XOT
M[3IEM]8N%B-NV[:6&P%@I['G]<]JQ-&TSQ!IWB[P^-<FD(>1_*BDN1(R?*<\
M9.*:J-^6GZ WHS+LO!\)GU2ZU&Z>UT>PFDB$^!OE96( 4=S_ /J^F)8Z'?ZU
M<2KI-C<3QH3S@?*.VX\#->AZC>6OCA]3\.[$L[^RN':R^8[9=I(;/N>3^/L:
M7PTKGP0=-M=/DN=0MKIA=VB7AM9 <G#;AU&,#'M[5*J22N]]/^'&SSF/0=4E
MU1M,6QF^VJ"3"1AL#OS3K[PYK&FV27EYIT\-N^,.R\#/3/I^->FV=[//\1K"
M"[T];.YM[%U8BZ$Y92,C<V!R.>M<WHNH7FH^$_%PO;F6X"HCJ)6+8)9N1GIT
M'Y57M)6O_6]@6K^[\5<P8O!7B.>%)8M*F:-U#*P*\@]#UI+S1X;/PM%=R6UY
M'?&[:!W?;Y7&>!CG.1^AKO\ 2=*\3:1X36:R\^^U2\0!!)<CR[6/'& S %L>
MG].<Z"1+#PCH#ZKG$.N-]H+'=@@ODD]\'FCG;E;S)YO=4OZV.*G\+ZY;:=]O
MFTNX2V W%V7H/4CJ![D5FVL0GNX822!)(JDCMDXKVO4;F_LK^_U*/13<V?DE
MOM+ZOB*6/'01D$#\OQYKQG3R#JMJ0,#STP/3YA54IN;U">D&UY_D=S>>"_"M
MMJO]CMXAN(=18JBI) 2NY@",D #G([US$GA'6?[:N]+MK.2YFMFVNT8^7!Y!
MR>!D<\UVOBOQ/I>C>+[C=X<@NKZ'8RW4DQ^]M!!VX[<?E53PXDNN6&L:[)#<
M:CJ4MPJM8V]VUNI7 PQVG) R0,^E9PE+EYF5+30XH^']675ETIK"9;YQE86&
M"PP3D=B, _E6II'@;5]1U.WM;FWELXI@[><Z [0O?;D9&2!^->BSJP\7>#6D
MA,,OD7"NC2^:4Q']TO\ Q8R>:Y'0-9O)OBDGVN_F,9N9HL/(=N,, N.F,@<?
M2K4V]/)_@VB7M<YZX\(:U#J%U9QV$TKVXWG:!DH20K8SWP>*IZIH.JZ*(SJ-
MC+;B3[C,.#[9'&?:O1-/CU?2[GQE+>O-'<BR:6W=I-Q"9DVD')Q].U9%IJ+3
M_#ZTN-4EDN(H-<0,9"6/EA<D<_4TH3DTGZ?B5U:]?RN<Q_PBVNC33J!TNY%J
M%W;RG.WUQUQ[XIEEX<UC4;:.YL]/FGADD\M709RWI[?6O8KZYOX]6?5+'2#>
MV@AWI=?VOLA9=O3RR"!^6.^:XV34Y[;X5O/8.]IY^INN(GP50Y.T$8] *2JR
M?3M^8EJTN_\ E<Y.T\*:[?12RVNF3RI$Q1F &-P."!Z\^F:R9(Y(96BE1DD0
ME61A@J1V(KUCPK'J>H^'M,MKNPFDM-S&._LK_P N2'+'EU!&3W[_ $S7#ZEX
M8NMFLZE;7"75C971B>9GR[DD<^_49/Y5:G[S4@6J(?"6A0^(M=73YY7B0QN^
MY ,\#/>HK3POK6H1)-9:?-/#([(CKC!(Z_3IWK:^&/\ R.<?_7"3^57;N]NK
M+X4V#6MQ+ SZBZL8V*DCYSC(]P*)2:E9>7YLE:W]?TN<7<Z7?V=_]@N+2:.[
M) $)0[CGI@=_PJUJ/AK6M)MEN;[3IX(6_C89 ^N.GXUZ1!J%NOB[PY=:A*BS
MW&B((YI.@F;."3[\C\:Y+7-!\86MC,^JW,K6SW"KMDO PE8GA@N>G^<<<'.[
MJ+_K6VA7]?A<X^DK2US1+OP_J)L;WR_."!_W;;A@UFUJFFKH04444P"DI:2@
M HHI*!!1110 4444 %)110 4444P"BBB@04E%% !1124 %%%% !2444 %%%%
M @HHHH *2BB@#H/"/A^'Q'J-U;3S21+#:O."@&25(XY^M<_7=?"M&E\0W\:#
M+-I\J@>I)6J'_"%ZWH<L&I:QIFS3K>:-KAO.C;Y-P!X#$FLW*U2S>EE^;#II
M_6AFQ^$]?ETW^T(])NFM<;@X3DCU ZD>^*@T[P_JVK6[3V%C+<1HXC9HQG#'
MM^M>J3V?B.X\>0:U:ZB/^$>^203+< 0B$+\RE<_7MWS],E]21/!OC&]T>5H(
MGU)?*>([3M+("1Z Y/YUG[5_UTUMJ.W]?(\^U#0]4TJ\2TOK&:&>3[B%<[_]
MW'7\*T&\#^)E*!M'N!O!8<#MZ\\'V-=G::S'#I_@34]6F+JDMRKS2?,0,[5)
M/MQ^5;OAZROH/%VH7<_B.WO;2ZCD>"WBN3(64G(.WHH4<9'KBB=244_*_P"
M6V\['DFE^&]9UN-I-.TZ:XC4X+J,+GTR>,^U56TN_74O[.-G/]MW;/(V'?GZ
M5Z%X5TG9X,M[ZQL;O5KF>X;S8(=1:V6WP2 2%(YP!R?6NDO9X(O']Q$LL=OJ
M5YHRI:3.P($I9N_<\#GVJI56I-)=_P $2MOZ[V/);WPKKNG36\5WID\37#B.
M+(!#,>BY'&?:F7OAK6M.B,MWIT\*>:(06'5R,@#U_"NHCT;Q7INJ:+)KL\WV
M=M3B"Q2W8D);</F"[C^=:FI:V8OC*B:G=O\ V?;3*$1V_=QDQ_*<=!\QSFFI
MMM)6>_X6&]+LX6_\+:[IE@+V]TNXAMCCYV7[N>F1U'XU7T72I=;UFUTV%U1[
MA]NYNBCJ3^ !KU[6[C4=-M=<N9_#SR64L;*\TNL[DE1N 4C(.#@]./05Y)X>
MAN9]?LDL[V*RN/,!CN)7VJA^OZ8[YQ13J.:=Q25D=-J/AKPA;"[LXO$=Q'J5
MH&WBX@(C=EZJ,#UZ<G\:YK2O#FL:W'))INGS7"1\,Z@  ^F3U/M7K4=GJVHQ
MW<7CC1],^PPP,1J2,H?([@@Y&>O05@6UKJFL_#?2K?PM,XEMIW%W#%,(W)))
M!)R..<_B/2LXU&EO?;TU_K8II'#GPMKBW5I:MILRSW89H(V #.%&3P>F/>JT
M&CZA=1WKPVKNMDNZY(Q^['/7\C7L%Y+):>+/ W]HW,;SK;S1RS;LAI#&%Z]\
MM658^'-3T/1_&TVH0K$ES YAQ(K%P-YW8!X'(ZTW6:7]=[?EJ)+]#S^R\)>(
M-1LOMEII5S+;XR'"XW#_ &<\G\*K6.A:IJ2W)L[&:;[,0)@J\H22 ,=<Y!XK
MUC0M).FP^'SI]E=ZA \:2R7_ /:;1QP%CE@(\X(&3QCGIUJ%)I-.O/B+/9N8
M98UC=&3@JQ5SD>^33E6:;\K_ (-+]115TOE^)YI#X6URXU2738M-G>[A ,L8
M ^3(R-QZ#CU-4=0TV]TJ[:UO[:2WG49*2+@X]1ZCWKT_P/>G4?!>H6T$,NH:
MJ;GS)X?MQMY95P #YG7 QC\*P/B1>74CZ597NEBRGMX21F]^TN5;& QP#D8[
MD]:KVDN?E_K8$KJY3\*^&=(U70]1U75]0GL[>S=%+1)NX;VP3UQ2ZWX1T^/0
M6USP_JQU"QCE$,JO$4=&. .N,\D=AU[UJ^"[JULOA]XBN+RQ6^MTFBWV[.4#
M\@=0/7G\*SKGQ5;:W#9^'K/3;?1=*GND-R8WWEOF W%B!TZ_@*'SN;2\O^"*
M+]V[\_P,:X\(>(;33C?SZ1<QVRC<S,G*CU*]0/J*99^%=<U"V@N;339IH)]W
MENN,';P?H,CO7M.EZ?)9Z]=VW]EW:V?V<QK?W&I-,+@8''EDD>O3ICWQ7!:A
MJ-Y8?!_0%M+F6#S;B59#$Q4L SG&1VJ56;6G=?C?_(KE,>[\ ZG:^$[?7 '<
MN&>:#RP/)C&2'+9Y!&#T[U37P1XF<,5T>Y(5!)D <@],<\GV'-=5<C5=4^$.
MG/8SSS?9I)?MFV;!$8W<-D\C&..>,5H^(]6U"U^(WABV@O)H[=HK8-$KD*=S
MD-D=\BFIS<W%=W^5R>B?E^IYEI^C:EJMXUI8V4T]POWD5?N?[WI^-2S^'=7M
M=6BTN>PFCO92!'$PQOSZ'H:]6T2>%KGQCI]K;^?J;:@\@MTN?LSRQYQA7'3'
MS?G[U7N[N[7Q+X2TZ_T;[#+'<>9$SZA]ID"\@JQQGT/4_P" JK;2M_5KCFN5
M2\K_ *?YGFDWA;7;<Q++I=RK33&"-=O+N.H []#STXIFK>&]9T-$?4M/FMT?
MA7894GTR,C/M7:KJ^N3_ !;N/LLBW4EO<3)%;7$^R/: 5VKGH<>G?\:D^(&F
M!/#,&H3I?:;<M=8_LZYO?M",2#ETY./T^G2A5)>[?J-Q]YQ['F-%%%=!F%%%
M% !2444 %%%% !1110(*2BB@ I*** "BBBF 4E%% !1110(**** "DHHH **
M** "BBDH$%%%% !1124 %%%%, I*** "BBB@04444 %)110 4444 %)2TE !
M1124".JHHHKF/4"DHHH ****!!1110 4E%% !1110 4E%%,04E+24 %%%% !
M1110 4E+24 %%%% @HHI* "BBB@ I***8!1110 4E+24""BBB@ HHHH *2EI
M* "BBB@ HHHH$%)110 444E !1110 4X2.(S&'8(3DKG@_A3:2@!02"".#2N
M[R.7=V9CU+')IM% @IR.\;AT9E8="IP:;13 "23DG)-)5J'3KZXC$D%E<2QG
MHR1,P/X@5!+%)!(8Y8VC=>JNN"/P- #***F-I<K:K=&WE%NS;1*4.PGTSTS0
M!&9',8C+L4!R%SP#]*914B6\TD3RI#(T<?WW520OU/:@1'3DD>)MT;LAQC*G
M%+%#+<2B*&-Y)&Z*BDD_@*8RLC%6!# X((Y!H 2BBB@!SN\CEG9F8]2QR33:
M** '>8XC,>]MA.=N>,_2F4M)0 ])9$5E1V4,,, <9'O5F'4KFWTVYL(F58+E
ME:7"_,VW.!GTR<XJG11804444P"G/([A0[LP484$YP/:FTE #F=G;<[%F/<G
M)IM%% !1124 %%%% @I*** "BBB@ I*6DH ****8!1110(*2BB@ HHI* "BB
MB@ I*6DH ****!!1110 444E !12@$D #)/0"K,VF:A;QF2:QN8XQU9XF 'X
MD4 5:***!#A+((S&'81DY*YX)^E-HI* )[2ZDLKR"ZB"&2%Q(H==PR#D9%=-
M+\0=1^S7,5GINDZ?)<J5EGL[;RY&!Z\Y-8 T;5" 1IMX0?\ I@W^%59[>>VD
M\NXADBD SMD4J?R-2U&6C&M-4-621 P1V4,,, <9'O3***L0Z2624@R.SD#
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M110 444E @HHHH **** "BBDH **** "BBB@04E+24 %%%)0 4444 %%%)0
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MVLT;AMA]#Z4ZY\-ZC:6S7$RQB((&W;QSGL/4T68<R[F116Q/X9U*VLVN9$B
M1=[IY@W*/4BLJ&&2XF2&%&>1SA54<DT6=[#4DU<925K7OAS4+"T-S,L6Q<;P
ML@)3/3(J2+PKJLULLRPH"PW+$S@.P]<468N9=S%I*T['0;_48YG@C4>2X1P[
M;2I_'TJT/".K><8RD(7 *R&0;7ST /<T<K%S1[F%14MS;RVEQ);SH4EC.&4]
MC45(H***2@ HHHI@%%%% !1124""BBB@ I*** "BBDH ****!!1110 444E
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MHHHH *2BB@ HHHI@%)110(**** "BBB@ I*** "BBB@ HHI*!!1110 444E
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MSESR3WXKR:KA-RE;R3^\&K)^K04445J2%)110 4444 %%%% A**** "DHHH
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M1110 444E, HHHH$%%%% !1124 %%%% !1110(2BBB@ HHHH 2BBBF 444E
M!1110(**** "BBDH **** "BBDH ****!"4444 %%%% !1124P"BBB@ HHHH
M$=31117*>H%)113$%%%)0 4444 %%%% !1124 %%%% @HHHH 2BBB@ I***8
M!1110 444E @HHHH **** "BBDH **** "BBB@04E%% !1124 %%%% !1124
M %%%% @HHHI@%%%)0 4444 %)2TE !1124""BBB@ HHHH ***2@ HHHH ***
M*8@HHI* "BBB@ HHI* "BBB@04E%% !1110 444E !1113 ****!!24M)0 4
M44E !1110 444E !1110(**** "BBDH **** "BBB@ HHI*!!1110 4E%%,
MHHI* "BBB@04444 %%%)0 4444 %%%%,0E%%% !1110 444E !1110(2BBB@
M HHHH ***2@ HHHH ****!!2444 %%%)0 4444 %%%)3 ****!!1110 444E
M !1110 4444 %)110(**** "DHHI@%%%)0 4444 %%%% @HHI* "BBB@ HHI
M* "BBB@04E%% !1110 444E, HHHH ****!!1124 =524M)7,>H%%%)0(***
M* "BBB@ HHI* "BBB@ HHHH$%)110 4E+24 %%%%, HHI*!!1110 4444 %%
M%)0 4444 %%%% @HHI* "BBDH **** "BBDH ****!!1113 ***2@ HHHH *
M**2@ HHHH$)1110 4444 %%%)0 4444 %%%%,0444E !1110 4444 %)110
M4E%% @HHHH ***2@ HHHI@%%%% @HHI* "BBB@ I*** "BBDH ****!!1110
M 444E !1110 4444 %%%)0(**** "DI:2F 444E !1110(**** "BBDH ***
M* "BBBF(*2BB@ HHHH ***2@ HHHH *2BB@04444 %%%)0 4444 %%%% @HH
MI* "BBDH **** "BBDI@%%%% @HHHH ***2@ HHHH **** "DHHH$%%%% !2
M444P"BBB@!**** "BBB@04444 )1110 4444 %)110 4E%% @HHHH ****8"
M4444 %%%% @HHI* "BBB@#J:***YCTQ**** "BBB@ HHHH 2BBB@ HHHH$%)
M110 444E !1113 **** $HHHH$%%%% !1110 E%%% !1110(***2@ HHHH *
M2BB@ HHHH 2BBB@04444P"BBB@!**** "BBDH ****!!2444 %%%% !1110
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M.[G 4!QDDGH*RZ*N*2;:ZB>UCK=9\2:>BZM9:5I2P&]FQ/<M=&7S%5]WRC
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M%%% !2444 %%%)0(**** "BBB@ I*** "BBBF(**** "DHHH **** "BBDH
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M6DH ***2@ HHHH **** $HHHIB"BBB@ HHHH 2BBB@ I*6DH ****!"4444
M%%%% !1110 E%%% !1113$%%%% "4444 %%%% "4444""DHHH **** "BBB@
M!****8!1110(*2EI* "BBB@!**** "BBB@!****!!1110 4444 )1110 444
M4 %%%% A**** "DI:2F 4444 )1110(**** "BBB@!**** "BBBF(2BBB@ H
MHHH ***2@ HHHH$)1110 4444 %%%% "4444 %%%% @I*6DH ***2@ HHHH
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
